Lam Research (LRCX) 10-Q 4 Feb 20 2020 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Dec. 29, 2019	Jan. 31, 2020
Cover page.
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 29, 2019
Document Transition Report	false
Entity File Number	0-12933
Entity Registrant Name	LAM RESEARCH CORPORATION
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	94-2634797
Entity Address, Address Line One	4650 Cushing Parkway,
Entity Address, City or Town	Fremont,
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94538
City Area Code	510
Local Phone Number	572-0200
Title of 12(b) Security	Common Stock, Par Value $0.001 Per Share
Trading Symbol	LRCX
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		145,548,470
Amendment Flag	false
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q2
Entity Central Index Key	0000707549
Current Fiscal Year End Date	--06-28

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 29, 2019	Dec. 23, 2018	Dec. 29, 2019	Dec. 23, 2018
Income Statement [Abstract]
Revenue	$ 2,583,501	$ 2,522,673	$ 4,749,247	$ 4,853,364
Cost of goods sold	1,403,857	1,377,640	2,587,893	2,650,133
Gross margin	1,179,644	1,145,033	2,161,354	2,203,231
Research and development	318,861	285,556	605,688	577,228
Selling, general, and administrative	174,272	169,098	331,700	343,873
Total operating expenses	493,133	454,654	937,388	921,101
Operating income	686,511	690,379	1,223,966	1,282,130
Other expense, net	(13,924)	(30,649)	(26,652)	(31,026)
Income before income taxes	672,587	659,730	1,197,314	1,251,104
Income tax expense	(158,077)	(90,875)	(217,015)	(148,889)
Net income	$ 514,510	$ 568,855	$ 980,299	$ 1,102,215
Net income per share:
Basic (usd per share)	$ 3.57	$ 3.67	$ 6.79	$ 7.10
Diluted (usd per share)	$ 3.43	$ 3.51	$ 6.52	$ 6.73
Number of shares used in per share calculations:
Basic (shares)	143,987	155,022	144,330	155,340
Diluted (shares)	150,097	162,170	150,389	163,749

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 29, 2019	Dec. 23, 2018	Dec. 29, 2019	Dec. 23, 2018
Statement of Comprehensive Income [Abstract]
Net income	$ 514,510	$ 568,855	$ 980,299	$ 1,102,215
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment	7,511	(7,268)	(1,187)	(13,529)
Cash flow hedges:
Net unrealized gains during the period	4,079		3,388
Net unrealized gains during the period		5,122		11,988
Net losses (gains) reclassified into earnings	1,384		2,734
Net losses (gains) reclassified into earnings		(5,726)		(4,578)
Net change	5,463		6,122
Net change		(604)		7,410
Available-for-sale investments:
Net unrealized (losses) gains during the period	(1,713)	585	(2,713)	298
Net losses (gains) reclassified into earnings	593	(51)	983	(54)
Net change	(1,120)	534	(1,730)	244
Defined benefit plans, net change in unrealized component	459	375	578	(1,368)
Other comprehensive income (loss), net of tax	12,313	(6,963)	3,783	(7,243)
Comprehensive income	$ 526,823	$ 561,892	$ 984,082	$ 1,094,972

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands		Dec. 29, 2019	Jun. 30, 2019
ASSETS
Cash and cash equivalents		$ 3,035,887	$ 3,658,219	[1]
Investments		1,647,867	1,772,984	[1]
Accounts receivable, less allowance for doubtful accounts of $5,357 as of December 29, 2019, and $5,021 as of June 30, 2019		2,030,490	1,455,522	[1]
Inventories		1,528,620	1,540,140	[1]
Prepaid expenses and other current assets		212,101	133,544	[1]
Total current assets		8,454,965	8,560,409	[1]
Property and equipment, net		1,047,254
Property and equipment, net	[1]		1,059,077
Restricted cash and investments		253,907	255,177	[1]
Goodwill		1,484,824	1,484,597	[1]
Intangible assets, net		193,116	216,950	[1]
Other assets		480,056	425,123	[1]
Total assets		11,914,122	12,001,333	[1]
LIABILITIES AND STOCKHOLDERS’ EQUITY
Trade accounts payable		452,779	376,561	[1]
Accrued expenses and other current liabilities		1,114,013	946,641	[1]
Deferred profit		366,417	381,317	[1]
Current portion of long-term debt and finance lease obligations		632,292	667,131	[1]
Total current liabilities		2,565,501	2,371,650	[1]
Long-term debt and finance lease obligations, less current portion		3,786,067	3,822,768	[1]
Income taxes payable		872,778	892,790	[1]
Other long-term liabilities		272,043	190,821	[1]
Total liabilities		7,496,389	7,278,029	[1]
Commitments and contingencies				[1]
Temporary equity, convertible notes		38,304	49,439	[1]
Stockholders’ equity:
Preferred stock, at par value of $0.001 per share; authorized, 5,000 shares, none outstanding		0	0	[1]
Common stock, at par value of $0.001 per share; authorized, 400,000 shares; issued and outstanding, 142,462 shares at December 29, 2019, and 144,433 shares at June 30, 2019		142	144	[1]
Additional paid-in capital		6,528,821	6,409,405	[1]
Treasury stock, at cost; 143,917 shares at December 29, 2019, and 140,573 shares at June 30, 2019		(12,673,292)	(11,602,573)	[1]
Accumulated other comprehensive loss		(60,247)	(64,030)	[1]
Retained earnings		10,584,005	9,930,919	[1]
Total stockholders’ equity		4,379,429	4,673,865	[1]
Total liabilities and stockholders’ equity		$ 11,914,122	$ 12,001,333	[1]
[1]	Derived from audited financial statements

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Dec. 29, 2019	Jun. 30, 2019
Statement of Financial Position [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 5,357	$ 5,021
Preferred stock, par value (usd per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	5,000,000	5,000,000
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (usd per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	400,000,000	400,000,000
Common stock, shares issued (in shares)	142,462,000	144,433,000
Common stock, shares outstanding (in shares)	142,462,000	144,433,000
Treasury stock, shares (in shares)	143,917,000	140,573,000

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Dec. 29, 2019	Dec. 23, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 980,299	$ 1,102,215
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	130,194	161,599
Deferred income taxes	74,516	(62,704)
Equity-based compensation expense	88,630	89,149
Amortization of note discounts and issuance costs	3,250	2,276
Other, net	3,699	848
Changes in operating assets and liabilities	(508,613)	69,322
Net cash provided by operating activities	771,975	1,362,705
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets	(101,310)	(162,021)
Purchases of available-for-sale securities	(1,619,695)	(785,188)
Maturities of available-for-sales securities	952,327	364,720
Sales of available-for-sale securities	795,559	581,108
Other, net	(10,528)	(4,019)
Net cash provided by (used for) investing activities	16,353	(5,400)
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on debt	(46,952)	(86,271)
Net repayments of commercial paper	0	(359,604)
Treasury stock purchases	(1,083,199)	(1,737,414)
Dividends paid	(325,589)	(342,279)
Reissuance of treasury stock related to employee stock purchase plan	38,447	32,920
Proceeds from issuance of common stock	4,501	109
Other, net	0	(13,207)
Net cash used for financing activities	(1,412,792)	(2,505,746)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	862	(5,032)
Net decrease in cash, cash equivalents, and restricted cash	(623,602)	(1,153,473)
Cash, cash equivalents, and restricted cash at beginning of period	3,913,396	4,768,558
Cash, cash equivalents, and restricted cash at end of period	3,289,794	3,615,085
Schedule of non-cash transactions:
Accrued payables for stock repurchases	289	4
Accrued payables for capital expenditures	27,966	36,582
Transfers of inventory to property and equipment, net	27,472	33,723
Reconciliation of cash, cash equivalents, and restricted cash
Total cash, cash equivalents, and restricted cash	$ 3,289,794	$ 3,615,085

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total		Common Stock	Additional Paid-in Capital	Treasury Stock	Accumulated Other Comprehensive Loss	Retained Earnings
Beginning balance (shares) at Jun. 24, 2018			156,892
Beginning balance at Jun. 24, 2018	$ 6,501,851		$ 157	$ 6,144,425	$ (7,846,476)	$ (57,449)	$ 8,261,194
Increase (Decrease) in Stockholders' Equity
Sale of common stock (shares)			79
Sale of common stock	109			109
Purchase of treasury stock (shares)			(9,491)
Purchase of treasury stock	(1,737,302)		$ (9)		(1,737,293)
Reissuance of treasury stock (shares)			273
Reissuance of treasury stock	32,920			22,637	10,283
Equity-based compensation expense	89,149			89,149
Effect of conversion of convertible notes (shares)			2,103
Effect of conversion of convertible notes	(20,547)		$ 2	(20,549)
Exercise of warrants (shares)			4,105
Exercise of warrants	(8)		$ 4	(12)
Reclassification from temporary to permanent equity	21,183			21,183
Adoption of ASU 2018-02 | ASU 2018-02						(2,227)	2,227
Net income	1,102,215						1,102,215
Other comprehensive income (loss)	(7,243)
Other comprehensive loss	(5,016)					(5,016)
Cash dividends declared	(339,103)						(339,103)
Ending balance (shares) at Dec. 23, 2018			153,961
Ending balance at Dec. 23, 2018	5,784,363		$ 154	6,256,942	(9,573,486)	(64,692)	9,165,445
Beginning balance (shares) at Sep. 23, 2018			153,384
Beginning balance at Sep. 23, 2018	5,322,825		$ 153	6,195,024	(9,582,409)	(57,729)	8,767,786
Increase (Decrease) in Stockholders' Equity
Sale of common stock (shares)			47
Sale of common stock	109			109
Purchase of treasury stock (shares)			(1,683)
Purchase of treasury stock	(1,361)		$ (1)		(1,360)
Reissuance of treasury stock (shares)			273
Reissuance of treasury stock	32,920			22,637	10,283
Equity-based compensation expense	38,806			38,806
Effect of conversion of convertible notes (shares)			141
Effect of conversion of convertible notes	(1,435)			(1,435)
Exercise of warrants (shares)			1,799
Exercise of warrants	0		$ 2	(2)
Reclassification from temporary to permanent equity	1,803			1,803
Net income	568,855						568,855
Other comprehensive income (loss)	(6,963)					(6,963)
Cash dividends declared	(171,196)						(171,196)
Ending balance (shares) at Dec. 23, 2018			153,961
Ending balance at Dec. 23, 2018	5,784,363		$ 154	6,256,942	(9,573,486)	(64,692)	9,165,445
Beginning balance (shares) at Jun. 30, 2019			144,433
Beginning balance at Jun. 30, 2019	4,673,865	[1]	$ 144	6,409,405	(11,602,573)	(64,030)	9,930,919
Ending balance (shares) at Sep. 29, 2019			144,871
Ending balance at Sep. 29, 2019	4,936,393		$ 145	6,456,492	(11,680,689)	(72,560)	10,233,005
Beginning balance (shares) at Jun. 30, 2019			144,433
Beginning balance at Jun. 30, 2019	4,673,865	[1]	$ 144	6,409,405	(11,602,573)	(64,030)	9,930,919
Increase (Decrease) in Stockholders' Equity
Sale of common stock (shares)			183
Sale of common stock	4,501			4,501
Purchase of treasury stock (shares)			(3,639)
Purchase of treasury stock	(1,083,459)		$ (3)		(1,083,456)
Reissuance of treasury stock (shares)			296
Reissuance of treasury stock	38,447			25,710	12,737
Equity-based compensation expense	88,630			88,630
Effect of conversion of convertible notes (shares)			1,189
Effect of conversion of convertible notes	(10,559)		$ 1	(10,560)
Reclassification from temporary to permanent equity	11,135			11,135
Net income	980,299						980,299
Other comprehensive income (loss)	3,783					3,783
Cash dividends declared	(330,231)						(330,231)
Ending balance (shares) at Dec. 29, 2019			142,462
Ending balance at Dec. 29, 2019	4,379,429		$ 142	6,528,821	(12,673,292)	(60,247)	10,584,005
Beginning balance (shares) at Sep. 29, 2019			144,871
Beginning balance at Sep. 29, 2019	4,936,393		$ 145	6,456,492	(11,680,689)	(72,560)	10,233,005
Increase (Decrease) in Stockholders' Equity
Sale of common stock (shares)			72
Sale of common stock	632			632
Purchase of treasury stock (shares)			(3,242)
Purchase of treasury stock	(1,005,343)		$ (3)		(1,005,340)
Reissuance of treasury stock (shares)			296
Reissuance of treasury stock	38,447			25,710	12,737
Equity-based compensation expense	45,725			45,725
Effect of conversion of convertible notes (shares)			465
Effect of conversion of convertible notes	(3,987)			(3,987)
Reclassification from temporary to permanent equity	4,249			4,249
Net income	514,510						514,510
Other comprehensive income (loss)	12,313					12,313
Cash dividends declared	(163,510)						(163,510)
Ending balance (shares) at Dec. 29, 2019			142,462
Ending balance at Dec. 29, 2019	$ 4,379,429		$ 142	$ 6,528,821	$ (12,673,292)	$ (60,247)	$ 10,584,005
[1]	Derived from audited financial statements

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Stockholders' Equity (Parenthetical) - $ / shares	3 Months Ended		6 Months Ended
	Dec. 29, 2019	Dec. 23, 2018	Dec. 29, 2019	Dec. 23, 2018
Statement of Stockholders' Equity [Abstract]
Dividends declared per share (usd per share)	$ 1.15	$ 1.10	$ 2.3	$ 2.20

BASIS OF PRESENTATION

BASIS OF PRESENTATION	6 Months Ended
	Dec. 29, 2019
Accounting Policies [Abstract]
BASIS OF PRESENTATION	BASIS OF PRESENTATION The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. The accompanying unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements of Lam Research Corporation (“Lam Research” or the “Company”) for the fiscal year ended June 30, 2019 , which are included in the Company’s Annual Report on Form 10-K as of and for the year ended June 30, 2019 (the “2019 Form 10-K”). The Company’s reports on Form 10-K, Form 10-Q and Form 8-K are available online at the Securities and Exchange Commission website on the Internet. The address of that site is www.sec.gov . The Company also posts its reports on Form 10-K, Form 10-Q and Form 8-K on its corporate website at http://investor.lamresearch.com . The content on any website referred to in this Form 10-Q is not a part of or incorporated by reference in this Form 10-Q unless expressly noted. The condensed consolidated financial statements include the accounts of Lam Research and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The Company’s reporting period is a 52/53-week fiscal year. The Company’s current fiscal year will end June 28, 2020 and includes 52 weeks. The quarters ended December 29, 2019 (the “ December 2019 quarter”) and December 23, 2018 (the “ December 2018 quarter”) included 13 weeks. Reclassifications: Certain prior fiscal year balances have been reclassified to conform to the current fiscal year presentation.

RECENT ACCOUNTING PRONOUNCEMENT

RECENT ACCOUNTING PRONOUNCEMENTS	6 Months Ended
	Dec. 29, 2019
Accounting Changes and Error Corrections [Abstract]
RECENT ACCOUNTING PRONOUNCEMENTS	RECENT ACCOUNTING PRONOUNCEMENTS Recently Adopted In February 2016, the FASB issued ASU 2016-02, “Leases.” The amendment establishes the principles that lessees and lessors shall apply to report useful information to users of financial statements about the amount, timing, and uncertainty of cash flows arising from a lease. In January 2018 and July 2018 the FASB issued ASU 2018-01 and ASU 2018-11 amending the effects of ASU 2016-02, which in combination with ASU 2016-02 were codified as Accounting Standard Codification topic 842 (“ASC 842”). The Company adopted ASC 842 on the first day of the current fiscal year, July 1, 2019, under the modified-retrospective approach, applying the amendments to prospective reporting periods. Results for reporting periods beginning on or after July 1, 2019 are presented under ASC 842, while prior period amounts are not adjusted and continue to be reported in accordance with the historic accounting under ASC 840. The Company elected the package of practical expedients that allowed the Company not to reassess (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct lease costs for existing leases. The Company did not elect to use hindsight in connection with the adoption of ASC 842. The Company adopted ASC 842 by recording operating right-of-use assets of $110.8 million , net of deferred rent liabilities of $3.0 million that were reclassified to operating right-of-use assets, and operating lease liabilities of $113.8 million . The Company also recognized an adjustment of $3.0 million to retained earnings, net of tax; a reduction of $40.4 million to property and equipment, net; and a reduction of $43.8 million to finance leases ( $42.3 million of which was previously recognized in long-term debt and finance lease obligations, less current portion and the remaining was previously recognized in current portion of long-term debt and finance lease obligations) related to its de-recognition of its previously recorded build-to-suit arrangements. The adoption of the standard did not materially impact the Company’s Condensed Consolidated Statement of Operations and had no impact on cash flows. Updates Not Yet Effective In June 2016, the FASB released ASU 2016-13, “Financial Instruments – Credit Losses.” The amendment revises the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in more timely recognition of losses on financial instruments, including but not limited to, available for sale debt securities and accounts receivable. The FASB issued a subsequent amendment to the initial guidance in November 2019 within ASU 2019-11. The Company is required to adopt these amendments starting in the first quarter of fiscal year 2021 using a modified-retrospective approach. Early adoption is permitted. The Company is still evaluating the impact of this standard, but does not expect the adoption to have a material impact on its Condensed Consolidated Financial Statements. In November 2018, the FASB issued ASU 2018-18, "Collaborative Arrangements (Topic 808).” The amendment clarifies that certain transactions between participants in a collaborative arrangement should be accounted for under Topic 606 when the counterparty is a customer for a good or service that is a distinct unit of account. The amendment also precludes entities from presenting consideration from transactions with a collaborator that is not a customer together with revenue recognized from contracts with customers. The Company is required to adopt this standard starting in the first quarter of fiscal year 2021. The standard should be applied retrospectively to the period when the Company initially adopted ASC 606. The Company is currently evaluating the impact of adoptions on its Condensed Consolidated Financial Statements. In April 2019, the FASB issued ASU 2019-04,”Codification Improvements to Topic 326, Financial Instruments-Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments ”, that clarifies and improves areas of guidance related to the recently issued standards on credit losses (ASU 2016-13), hedging (ASU 2017-12), and recognition and measurement of financial instruments (ASU 2016-01). The amendments generally have the same effective dates as their related standards. If already adopted, the amendments of ASU 2016-01 and ASU 2016-13 are effective starting in the first quarter of fiscal year 2021. The amendments of ASU 2017-12 were effective in the first quarter of fiscal year 2020, and did not have a material impact on the Company’s Condensed Consolidated Financial Statements. The Company continues to evaluate the impact of ASU 2016-13 and will consider the amendments of ASU 2019-04 as part of that process.

REVENUE

REVENUE	6 Months Ended
	Dec. 29, 2019
Revenue from Contract with Customer [Abstract]
REVENUE	REVENUE Deferred Revenue Revenue of $125.9 million and $323.9 million included in deferred revenue at June 30, 2019 was recognized during the three and six months ended December 29, 2019 . The following table summarizes the transaction price for contracts that have not yet been recognized as revenue as of December 29, 2019 and when the Company expects to recognize the amounts as revenue: Less than 1 Year 1-3 Years More than 3 Years Total (In thousands) Deferred revenue $ 372,927 $ 37,834 (1) $ — $ 410,761 (1) This amount is reported in Deferred profit on the Company's Condensed Consolidated Balance Sheets as the customers can demand the liability to be performed at any time. Disaggregation of Revenue The Company operates in one reportable business segment: manufacturing and servicing of wafer processing semiconductor manufacturing equipment. The Company’s material operating segments qualify for aggregation due to their customer base and similarities in economic characteristics, nature of products and services, and processes for procurement, manufacturing, and distribution. The Company operates in seven geographic regions: United States, China, Europe, Japan, Korea, Southeast Asia, and Taiwan. For geographical reporting, revenue is attributed to the geographic location in which the customers’ facilities are located. The Company serves three primary markets: memory, foundry, and logic/integrated device manufacturing. The following table presents the Company’s revenues disaggregated by geographic region: Three Months Ended Six Months Ended December 29, December 23, December 29, December 23, (In thousands) China $ 758,286 $ 361,782 $ 1,349,954 $ 955,613 Taiwan 680,871 425,533 1,072,363 705,583 Korea 463,178 631,502 914,661 1,011,272 United States 223,725 135,696 407,384 255,801 Japan 208,240 691,817 481,913 1,361,857 Southeast Asia 184,168 165,204 397,923 363,340 Europe 65,033 111,139 125,049 199,898 $ 2,583,501 $ 2,522,673 $ 4,749,247 $ 4,853,364 The following table presents the percentages of system revenues to each of the primary markets we serve: Three Months Ended Six Months Ended December 29, December 23, December 29, December 23, Memory 52 % 79 % 58 % 78 % Foundry 36 % 13 % 31 % 15 % Logic/integrated device manufacturing 12 % 8 % 11 % 7 %

EQUITY-BASED COMPENSATION PLANS

EQUITY-BASED COMPENSATION PLANS	6 Months Ended
	Dec. 29, 2019
Share-based Payment Arrangement [Abstract]
EQUITY-BASED COMPENSATION PLANS	EQUITY-BASED COMPENSATION PLANS The Lam Research Corporation 2015 Stock Incentive Plan, as amended (the “2015 Plan”), provides for the grant of non-qualified equity-based awards of the Company’s Common Stock to eligible employees and non-employee directors, including stock options, restricted stock units (“RSUs”), and market-based performance RSUs (“market-based PRSUs”). An option is a right to purchase Common Stock at a set price. An RSU award is an agreement to issue a set number of shares of Common Stock at the time of vesting. The Company’s market-based PRSUs contain both a market condition and a service condition. The Company’s options, RSU, and market-based PRSU awards typically vest over a period of three years . The Company also has an employee stock purchase plan that allows employees to purchase its Common Stock at a discount through payroll deductions. The Company recognized the following equity-based compensation expense (including expense related to the employee stock purchase plan) and related income tax benefit in the Condensed Consolidated Statements of Operations: Three Months Ended Six Months Ended December 29, December 23, December 29, December 23, (in thousands) Equity-based compensation expense $ 45,725 $ 38,806 $ 88,630 $ 89,149 Income tax benefit recognized related to equity-based compensation expense $ 4,461 $ 5,763 $ 14,279 $ 13,867

OTHER EXPENSE, NET

OTHER EXPENSE, NET	6 Months Ended
	Dec. 29, 2019
Other Income and Expenses [Abstract]
OTHER EXPENSE, NET	OTHER EXPENSE, NET The significant components of other expense, net, are as follows: Three Months Ended Six Months Ended December 29, December 23, December 29, December 23, (in thousands) Interest income $ 25,454 $ 17,809 $ 57,238 $ 36,742 Interest expense (42,615 ) (19,784 ) (86,610 ) (41,572 ) Gains (losses) on deferred compensation plan-related assets, net 14,129 (22,374 ) 13,693 (17,160 ) Foreign exchange (losses) gains, net (2,287 ) 2,581 (2,816 ) 2,632 Other, net (8,605 ) (8,881 ) (8,157 ) (11,668 ) $ (13,924 ) $ (30,649 ) $ (26,652 ) $ (31,026 )

INCOME TAX EXPENSE

INCOME TAX EXPENSE	6 Months Ended
	Dec. 29, 2019
Income Tax Disclosure [Abstract]
INCOME TAX EXPENSE	INCOME TAX EXPENSE The Company recorded an income tax expense of $158.1 million and $217.0 million for the three and six months ended December 29, 2019 , which yielded an effective tax rate of approximately 23.5% and 18.1% , respectively. The difference between the U.S. federal statutory tax rate of 21% and the Company’s effective tax rate for the three months ended December 29, 2019 was primarily due to income in lower tax jurisdictions, U.S. taxation on low-taxed foreign income, and a cumulative income tax benefit reversal due to a court ruling, as outlined below. In November 2019, the U.S. Court of Appeals for the Ninth Circuit (“Ninth Circuit”) rejected the en banc appeal petitioned by Altera Corporation (“Altera”) in July 2019. The Company has evaluated the impact of this decision and views the denial as an indication that Altera’s position of excluding stock-based compensation expense in an inter-company cost-sharing arrangement is unlikely to be sustained upon further litigation. As a result, the Company has reversed $74.5 million of net tax assets associated with stock-based compensation benefits related to previous years in the Condensed Consolidated Financial Statements in the three months ended December 29, 2019. In conclusion, the Company is no longer reflecting a net tax benefit within its financial statements related to excluding stock-based compensation from its inter-company cost-sharing arrangement. If, at a future date, Altera secured a favorable ruling from the Supreme Court, the Company would re-evaluate the decision to record an income tax benefit at that time. Please refer to Note 7, “Income Taxes,” to the Company’s Consolidated Financial Statements in Part II, Item 8 of its 2019 Form 10-K for additional information. The Internal Revenue Service (“IRS”) is examining the Company’s U.S. federal income tax return for the fiscal year ended June 24, 2018. As of December 29, 2019 , no significant adjustments have been proposed by the IRS. The Company is unable to make a reasonable estimate as to when cash settlements, if any, with the IRS will occur. The Company is in various stages of examinations in connection with all of its tax audits worldwide, and it is difficult to determine when these examinations will be settled. It is reasonably possible that over the next 12-month period the Company may experience an increase or decrease in its unrecognized tax benefits as a result of tax examinations or lapses of statute of limitations. The change in unrecognized tax benefits may range up to $10.0 million .

NET INCOME PER SHARE

NET INCOME PER SHARE	6 Months Ended
	Dec. 29, 2019
Earnings Per Share [Abstract]
NET INCOME PER SHARE	NET INCOME PER SHARE Basic net income per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the treasury stock method, for dilutive stock options, restricted stock units, convertible notes, and warrants. Dilutive shares outstanding include the effect of the convertible notes. Refer to Note 12 - Long-term Debt and Other Borrowings for additional information regarding the Company’s convertible notes. The following table reconciles the numerators and denominators of the basic and diluted computations for net income per share. Three Months Ended Six Months Ended December 29, December 23, December 29, December 23, (in thousands, except per share data) Numerator: Net income $ 514,510 $ 568,855 $ 980,299 $ 1,102,215 Denominator: Basic average shares outstanding 143,987 155,022 144,330 155,340 Effect of potential dilutive securities: Employee stock plans 1,528 1,435 1,359 1,487 Convertible notes 4,582 5,713 4,700 5,894 Warrants — — — 1,028 Diluted average shares outstanding 150,097 162,170 150,389 163,749 Net income per share - basic $ 3.57 $ 3.67 $ 6.79 $ 7.10 Net income per share - diluted $ 3.43 $ 3.51 $ 6.52 $ 6.73 For purposes of computing diluted net income per share, weighted-average common shares do not include potentially dilutive securities that are anti-dilutive under the treasury stock method. The following potentially dilutive securities were excluded: Three Months Ended Six Months Ended December 29, December 23, December 29, December 23, (in thousands) Options and RSUs 3 227 4 890

FINANCIAL INSTRUMENTS

FINANCIAL INSTRUMENTS	6 Months Ended
	Dec. 29, 2019
Fair Value Disclosures [Abstract]
FINANCIAL INSTRUMENTS	FINANCIAL INSTRUMENTS The Company maintains an investment portfolio of various holdings, types, and maturities. The Company’s mutual funds, which are related to the Company’s obligations under the deferred compensation plan, are classified as trading securities. Investments classified as trading securities are recorded at fair value based upon quoted market prices. Differences between the cost and fair value of trading securities are recognized as other income (expense) in the Condensed Consolidated Statements of Operations. All of the Company’s other investments are classified as available-for-sale and consequently are recorded in the Condensed Consolidated Balance Sheets at fair value with unrealized gains or losses reported as a separate component of accumulated other comprehensive income (loss), net of tax. Fair Value The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact, and it considers assumptions that market participants would use when pricing the asset or liability. A fair value hierarchy has been established that prioritizes the inputs to valuation techniques used to measure fair value. The level of an asset or liability in the hierarchy is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are classified and disclosed in one of the following three categories: Level 1: Valuations based on quoted prices in active markets for identical assets or liabilities with sufficient volume and frequency of transactions. Level 2: Valuations based on observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or model-derived valuations techniques for which all significant inputs are observable in the market or can be corroborated by observable market data, for substantially the full term of the assets or liabilities. Level 3: Valuations based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities and based on non-binding, broker-provided price quotes and may not have been corroborated by observable market data. The Company’s primary financial instruments include its cash, cash equivalents, investments, restricted cash and investments, long-term investments, accounts receivable, accounts payable, long-term debt and leases, and foreign currency related derivative instruments. The estimated fair value of cash, accounts receivable, and accounts payable approximates their carrying value due to the short period of time to their maturities. The estimated fair values of lease obligations approximate their carrying value as the substantial majority of these obligations have interest rates that adjust to market rates on a periodic basis. Refer to Note 12 - Long-Term Debt and Other Borrowings for additional information regarding the fair value of the Company’s senior notes and convertible senior notes. The following table sets forth the Company’s cash, cash equivalents, investments, restricted cash and investments, and other assets measured at fair value on a recurring basis as of December 29, 2019 , and June 30, 2019 : December 29, 2019 (Reported Within) Cost Unrealized Unrealized Fair Value Cash and Investments Restricted Other (in thousands) Cash $ 580,318 $ — $ — $ 580,318 $ 576,439 $ — $ 3,879 $ — Time deposit 1,606,528 — — 1,606,528 1,356,500 — 250,028 — Level 1: Money market funds 977,274 — — 977,274 977,274 — — — U.S. Treasury and agencies 476,406 116 (54 ) 476,468 — 476,468 — — Mutual funds 75,244 5,792 (452 ) 80,584 — — — 80,584 Level 1 Total 1,528,924 5,908 (506 ) 1,534,326 977,274 476,468 — 80,584 Level 2: Government-sponsored enterprises 9,819 — (3 ) 9,816 2,799 7,017 — — Foreign government bonds 30,507 2 (6 ) 30,503 — 30,503 — — Corporate notes and bonds 1,225,526 742 (444 ) 1,225,824 122,875 1,102,949 — — Mortgage backed securities — residential 4,172 8 — 4,180 — 4,180 — — Mortgage backed securities — commercial 26,751 34 (35 ) 26,750 — 26,750 — — Level 2 Total 1,296,775 786 (488 ) 1,297,073 125,674 1,171,399 — — Total $ 5,012,545 $ 6,694 $ (994 ) $ 5,018,245 $ 3,035,887 $ 1,647,867 $ 253,907 $ 80,584 June 30, 2019 (Reported Within) Cost Unrealized Unrealized Fair Value Cash and Investments Restricted Other (in thousands) Cash $ 467,460 $ — $ — $ 467,460 $ 462,310 $ — $ 5,150 $ — Time deposit 1,563,686 — — 1,563,686 1,313,659 — 250,027 — Level 1: Money market funds 1,644,659 — — 1,644,659 1,644,659 — — — U.S. Treasury and agencies 465,655 283 (24 ) 465,914 86,981 378,933 — — Mutual funds 76,961 1,063 (283 ) 77,741 — — — 77,741 Level 1 Total 2,187,275 1,346 (307 ) 2,188,314 1,731,640 378,933 — 77,741 Level 2: Government-sponsored enterprises 16,005 5 (41 ) 15,969 — 15,969 — — Foreign government bonds 24,408 35 — 24,443 — 24,443 — — Corporate notes and bonds 1,466,167 2,310 (99 ) 1,468,378 150,610 1,317,768 — — Mortgage backed securities — residential 6,148 — (4 ) 6,144 — 6,144 — — Mortgage backed securities — commercial 29,587 140 — 29,727 — 29,727 — — Level 2 Total 1,542,315 2,490 (144 ) 1,544,661 150,610 1,394,051 — — Total $ 5,760,736 $ 3,836 $ (451 ) $ 5,764,121 $ 3,658,219 $ 1,772,984 $ 255,177 $ 77,741 The Company accounts for its investment portfolio at fair value. Realized gains (losses) for investment sales are specifically identified. Management assesses the fair value of investments in debt securities that are not actively traded through consideration of interest rates and their impact on the present value of the cash flows to be received from the investments. The Company also considers whether changes in the credit ratings of the issuer could impact the assessment of fair value. Additionally, the Company also considers factors such as the Company’s intent to sell the security and whether it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. The Company did not recognize any losses on investments due to other-than-temporary impairments during the three and six months ended December 29, 2019 or December 23, 2018 . Additionally, gross realized gains/(losses) from sales of investments were insignificant in the three and six months ended December 29, 2019 and December 23, 2018 . The following is an analysis of the Company’s cash, cash equivalents, investments, and restricted cash and investments in unrealized loss positions: December 29, 2019 Unrealized Losses Unrealized Losses Total Fair Value Gross Fair Value Gross Fair Value Gross (in thousands) U.S. Treasury and agencies $ 325,502 $ (54 ) $ — $ — $ 325,502 $ (54 ) Mutual funds 2,925 (195 ) 7,955 (257 ) 10,880 (452 ) Government-sponsored enterprises — — 6,995 (3 ) 6,995 (3 ) Foreign government bonds 29,420 (6 ) — — 29,420 (6 ) Corporate notes and bonds 703,002 (441 ) 6,780 (3 ) 709,782 (444 ) Mortgage backed securities — commercial 16,805 (35 ) — — 16,805 (35 ) $ 1,077,654 $ (731 ) $ 21,730 $ (263 ) $ 1,099,384 $ (994 ) The amortized cost and fair value of cash equivalents, investments, and restricted investments with contractual maturities are as follows as of December 29, 2019 : Cost Estimated (in thousands) Due in one year or less $ 3,889,431 $ 3,889,377 Due after one year through five years 444,558 444,950 Due in more than five years 22,994 23,016 $ 4,356,983 $ 4,357,343 The Company has the ability, if necessary, to liquidate its investments in order to meet the Company’s liquidity needs in the next 12 months. Accordingly, those investments with contractual maturities greater than 12 months from the date of purchase nonetheless are classified as short-term on the accompanying Condensed Consolidated Balance Sheets. Derivative Instruments and Hedging The Company carries derivative financial instruments (“derivatives”) on its Condensed Consolidated Balance Sheets at their fair values. The Company enters into foreign currency forward contracts and foreign currency options with financial institutions with the primary objective of reducing volatility of earnings and cash flows related to foreign currency exchange rate fluctuations. In addition, the Company enters into interest rate swap arrangements to manage interest rate risk. The counterparties to these derivatives are large global financial institutions that the Company believes are creditworthy, and therefore, it does not consider the risk of counterparty nonperformance to be material. Cash Flow Hedges The Company’s financial position is routinely subjected to market risk associated with foreign currency exchange rate fluctuations on non-U.S. dollar transactions or cash flows, primarily from Japanese yen-denominated revenues and euro- denominated and Korean won-denominated expenses. The Company’s policy is to mitigate the foreign exchange risk arising from the fluctuations in the value of these non-U.S. dollar denominated transactions or cash flows through a foreign currency cash flow hedging program, using forward contracts and foreign currency options that generally expire within 12 months and no later than 24 months . These hedge contracts are designated as cash flow hedges and are carried on the Company’s balance sheet at fair value with the effective portion of the contracts’ gains or losses included in accumulated other comprehensive income (loss) and subsequently recognized in revenue/expense in the same period the hedged items are recognized. In addition, the Company has entered into interest rate swap agreements to hedge against the variability of cash flows due to changes in certain benchmark interest rates on fixed rate debt. These instruments are designated as cash flow hedges at inception and are settled in conjunction with the issuance of debt. The effective portion of the contracts’ gains or losses is included in accumulated other comprehensive income (loss) and is amortized into income as the hedged item impacts earnings. During the three and six months ended December 29, 2019 , the Company entered into a series of these interest rate swap agreements with a total notional value of $200 million . As of December 29, 2019 , the Company had a net gain of $1.9 million accumulated in other comprehensive income, net of tax, related to these interest rate swap agreements. Additionally, in January 2020, the Company entered into an additional series of interest rate swap agreements with a total notional value of $200 million . At inception and at each quarter-end, hedges are tested prospectively and retrospectively for effectiveness using regression analysis. Changes in the fair value of foreign exchange contracts due to changes in time value are included in the assessment of effectiveness. To qualify for hedge accounting, the hedge relationship must meet criteria relating to both the derivative instrument and the hedged item. These criteria include identification of the hedging instrument, the hedged item, the nature of the risk being hedged and how the hedging instrument’s effectiveness in offsetting the exposure to changes in the hedged item’s fair value or cash flows will be measured. There were no material gains or losses during the three and six months ended December 29, 2019 and December 23, 2018 associated with forecasted transactions that failed to occur. To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge, and the hedges must be tested to demonstrate an expectation of providing highly effective offsetting changes to future cash flows on hedged transactions. When derivative instruments are designated and qualify as effective cash flow hedges, the Company recognizes effective changes in the fair value of the hedging instrument within accumulated other comprehensive income (loss) until the hedged exposure is realized. Consequently, the Company’s results of operations are not subject to fluctuation as a result of changes in the fair value of the derivative instruments. If hedges are not highly effective or if the Company does not believe that the underlying hedged forecasted transactions will occur, the Company may not be able to account for its derivative instruments as cash flow hedges. If this were to occur, future changes in the fair values of the Company’s derivative instruments would be recognized in earnings. Additionally, related amounts previously recorded in other comprehensive income would be reclassified to income immediately. As of December 29, 2019 , the Company had a net gain of $2.0 million accumulated in other comprehensive income, net of tax, related to foreign exchange cash flow hedges which it expects to reclassify from other comprehensive income into earnings over the next 12 months . Additionally, as of December 29, 2019 , the Company had a net loss of $2.1 million accumulated in other comprehensive income, net of tax, related to interest rate contracts which it expects to reclassify from other comprehensive income into earnings over the next 5.2 years . Fair Value Hedges The Company has interest rate contracts whereby the Company receives fixed rates and pays variable rates based on certain benchmark interest rates, resulting in a net increase or decrease to interest expense, a component of other expense, net in our Condensed Consolidated Statement of Operations. These interest rate contracts are designated as fair value hedges and hedge against changes in the fair value of our debt portfolio. The Company concluded that these interest rate contracts meet the criteria necessary to qualify for the short-cut method of hedge accounting, and as such an assumption is made that the change in the fair value of the hedged debt, due to changes in the benchmark rate, exactly offsets the change in the fair value of the interest rate swap. Therefore, the derivative is considered to be effective at achieving offsetting changes in the fair value of the hedged liability, and no ineffectiveness is recognized. During the quarter ended September 29, 2019, the Company terminated and consequently discontinued the hedging relationship of selected interest rate contracts; refer to Note 12 - Long-Term Debt and Other Borrowings for additional information regarding the accumulated fair value adjustment and the related amortization. Balance Sheet Hedges The Company also enters into foreign currency forward contracts to hedge fluctuations associated with foreign currency denominated monetary assets and liabilities, primarily cash, third-party accounts receivable, accounts payable, and intercompany receivables and payables. These forward contracts are not designated for hedge accounting treatment. Therefore, the change in fair value of these derivatives is recorded as a component of other income (expense) and offsets the change in fair value of the foreign currency denominated assets and liabilities, which are also recorded in other income (expense). As of December 29, 2019 , the Company had the following outstanding foreign currency contracts that were entered into under its cash flow and balance sheet hedge programs: Notional Value Derivatives Designated as Derivatives Not Designated (in thousands) Foreign currency forward contracts Buy Contracts Sell Contracts Buy Contracts Sell Contracts Japanese yen $ — $ 100,830 $ 61,301 $ — Euro 61,007 — 42,371 — Korean won 15,401 — — 4,294 British pound sterling — — 48,439 — Taiwan dollar — — 33,328 — Chinese renminbi — — 31,683 — Swiss franc — — 22,493 — Singapore dollar — — 21,409 — Indian rupee — — 7,855 — $ 76,408 $ 100,830 $ 268,879 $ 4,294 The fair value of derivative instruments in the Company’s Condensed Consolidated Balance Sheet as of December 29, 2019 , and June 30, 2019 were as follows: December 29, 2019 June 30, 2019 Fair Value of Derivative Instruments (Level 2) Fair Value of Derivative Instruments (Level 2) Derivative Assets Derivative Liabilities Derivative Assets Derivative Liabilities Balance Sheet Fair Value Balance Sheet Fair Value Balance Sheet Fair Value Balance Sheet Fair Value (in thousands) Derivatives designated as hedging instruments: Foreign exchange contracts Prepaid expense $ 2,437 Accrued expenses and other current liabilities $ 16 Prepaid expense $ 119 Accrued expenses and other current liabilities $ 2,756 Interest rate contracts, short-term — Accrued expenses and other current liabilities 2,746 — Accrued expenses and other current liabilities 5,149 Interest rate contracts, long-term Other assets 3,605 — Other assets 1,537 — Derivatives not designated as hedging instruments: Foreign exchange contracts Prepaid expense 21 Accrued expenses and other current liabilities 200 Prepaid expense 1,249 Accrued expenses and other current liabilities 748 Total Derivatives $ 6,063 $ 2,962 $ 2,905 $ 8,653 Under the master netting agreements with the respective counterparties to the Company’s derivative contracts, subject to applicable requirements, the Company is allowed to net settle transactions of the same currency with a single net amount payable by one party to the other. However, the Company has elected to present the derivative assets and derivative liabilities on a gross basis on its balance sheet. As of December 29, 2019 , the potential effect of rights of offset associated with the above foreign exchange and interest rate contracts would be an offset to assets and liabilities by $2.3 million , resulting in a net derivative asset of $3.8 million and net derivative liability of $0.7 million . As of June 30, 2019 , the potential effect of rights of offset associated with the above foreign exchange and interest rate contracts would be an offset to both assets and liabilities by $2.4 million , resulting in a net derivative asset of $0.5 million and a net derivative liability of $6.2 million . The Company is not required to pledge, nor is the Company entitled to receive, cash collateral for these derivative transactions. The effect of derivative instruments designated as cash flow hedges on the Company’s Condensed Consolidated Statements of Operations, including accumulated other comprehensive income (“AOCI”) was as follows: Three Months Ended Six Months Ended December 29, 2019 December 29, 2019 Location of Gain Loss Gain (Loss) Loss Derivatives in Cash Flow Hedging Relationships (in thousands) Foreign Exchange Contracts Revenue $ 2,264 $ (172 ) $ 3,198 $ (506 ) Foreign Exchange Contracts Cost of goods sold 196 (1,090 ) (1,067 ) (1,900 ) Foreign Exchange Contracts Selling, general, and administrative 130 (417 ) (465 ) (893 ) Interest Rate Contracts Other expense, net 2,394 (35 ) 2,394 (70 ) $ 4,984 $ (1,714 ) $ 4,060 $ (3,369 ) Three Months Ended Six Months Ended December 23, 2018 December 23, 2018 Location of Gain (Loss) Gain (Loss) Gain (Loss) Gain (Loss) Derivatives in Cash Flow Hedging Relationships (in thousands) Foreign Exchange Contracts Revenue $ 8,229 $ 7,813 $ 16,670 $ 8,487 Foreign Exchange Contracts Cost of goods sold (1,965 ) (851 ) (2,089 ) (2,408 ) Foreign Exchange Contracts Selling, general, and administrative (674 ) (651 ) (878 ) (1,178 ) Interest Rate Contracts Other expense, net — (33 ) — (66 ) $ 5,590 $ 6,278 $ 13,703 $ 4,835 The effect of derivative instruments not designated as cash flow hedges on the Company’s Condensed Consolidated Statements of Operations was as follows: Three Months Ended Six Months Ended December 29, December 23, December 29, December 23, Derivatives Not Designated as Hedging Instruments: Location Gain Gain Loss Gain (in thousands) Foreign Exchange Contracts Other income $ 3,571 $ 301 $ (1,930 ) $ 10,889 The following table presents the effect of the fair value cash flow hedge accounting on the Statement of Financial Performance as well as presents the location and amount of gain/(loss) recognized in Income on fair value and cash flow hedging relationships: Three Months Ended Six Months Ended December 29, 2019 December 29, 2019 Revenue Cost of Goods Sold Selling, General and Admini-strative Other Income (Expense) Revenue Cost of Goods Sold Selling, General and Admini-strative Other Income (Expense) (in thousands) Total amounts of income and expense line items presented in the statement of financial performance in which the effects of fair value or cash flow hedges are recorded: $ 2,583,501 $1,403,857 $ 174,272 $ (13,924 ) $ 4,749,247 $ 2,587,893 $ 331,700 $ (26,652 ) The effects of fair value and cash flow hedging: Gain or (loss) on fair value hedging relationships in Subtopic 815-20: Interest contracts: Hedged items $ — $ — $ — $ 2,342 $ — $ — $ — $ (5,092 ) Derivatives designated as hedging instruments $ — $ — $ — $ (2,342 ) $ — $ — $ — $ 5,092 Gain or (loss) on cash flow hedging relationships in Subtopic 815-20: Foreign exchange contracts: Amount of loss reclassified from accumulated other comprehensive income into income $ (172 ) $ (1,090 ) $ (417 ) $ — $ (506 ) $ (1,900 ) $ (893 ) $ — Interest rate contracts: Amount of loss reclassified from accumulated other comprehensive income into income $ — $ — $ — $ (35 ) $ — $ — $ — $ (70 ) Concentrations of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, investments, restricted cash and investments, trade accounts receivable, and derivative financial instruments used in hedging activities. Cash is placed on deposit at large global financial institutions. Such deposits may be in excess of insured limits. Management believes that the financial institutions that hold the Company’s cash are creditworthy and, accordingly, minimal credit risk exists with respect to these balances. The Company’s overall portfolio of available-for-sale securities must maintain an average minimum rating of “AA-” or “Aa3” as rated by Standard and Poor’s, Fitch Ratings, or Moody’s Investor Services. To ensure diversification and minimize concentration, the Company’s policy limits the amount of credit exposure with any one financial institution or commercial issuer. The Company is exposed to credit losses in the event of nonperformance by counterparties on foreign currency and interest rate hedge contracts that are used to mitigate the effect of exchange rate and interest rate fluctuations, and on contracts related to structured share repurchase arrangements. These counterparties are large global financial institutions and, to date, no such counterparty has failed to meet its financial obligations to the Company. Credit risk evaluations, including trade references, bank references, and Dun & Bradstreet ratings, are performed on all new customers and the Company monitors its customers’ financial condition and payment performance. In general, the Company does not require collateral on sales.

INVENTORIES

INVENTORIES	6 Months Ended
	Dec. 29, 2019
Inventory Disclosure [Abstract]
INVENTORIES	INVENTORIES Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. System shipments to customers in Japan, for which title does not transfer until customer acceptance, are classified as finished goods inventory and carried at cost until title transfers. Inventories consist of the following: December 29, June 30, (in thousands) Raw materials $ 980,751 $ 994,738 Work-in-process 200,626 174,219 Finished goods 347,243 371,183 $ 1,528,620 $ 1,540,140

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS	6 Months Ended
	Dec. 29, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND INTANGIBLE ASSETS	GOODWILL AND INTANGIBLE ASSETS Goodwill The balance of goodwill is approximately $1.5 billion as of December 29, 2019 and June 30, 2019 , respectively. As of December 29, 2019 , $61.1 million of the goodwill balance is tax deductible and the remaining balance is not tax deductible due to purchase accounting and applicable foreign law. Intangible Assets The following table provides the Company’s intangible assets: December 29, 2019 June 30, 2019 Gross Accumulated Net Gross Accumulated Net (in thousands) Customer relationships $ 630,206 $ (508,199 ) $ 122,007 $ 630,165 $ (483,204 ) $ 146,961 Existing technology 669,488 (651,379 ) 18,109 669,399 (647,837 ) 21,562 Patents and other intangible assets 135,048 (82,048 ) 53,000 126,235 (77,808 ) 48,427 Total intangible assets $ 1,434,742 $ (1,241,626 ) $ 193,116 $ 1,425,799 $ (1,208,849 ) $ 216,950 The Company recognized $16.5 million and $36.3 million in intangible asset amortization expense during the three months ended December 29, 2019 and December 23, 2018 , respectively. The Company recognized $32.7 million and $72.7 million in intangible asset amortization expense during the six months ended December 29, 2019 and December 23, 2018 , respectively. The estimated future amortization expense of intangible assets as of December 29, 2019 , is reflected in the table below. The table excludes $13.5 million of capitalized costs for intangible assets that have not been placed into service. Fiscal Year Amount (in thousands) 2020 (remaining 6 months) $ 32,742 2021 63,431 2022 59,093 2023 14,025 2024 7,324 Thereafter 2,962 $ 179,577

ACCRUED EXPENSES AND OTHER CURR

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES	6 Months Ended
	Dec. 29, 2019
Payables and Accruals [Abstract]
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES	ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES Accrued expenses and other current liabilities consist of the following: December 29, June 30, (in thousands) Accrued compensation $ 390,033 $ 336,090 Warranty reserves 118,193 127,932 Income and other taxes payable 134,615 49,926 Dividend payable 163,510 158,868 Other 307,662 273,825 $ 1,114,013 $ 946,641

LONG-TERM DEBT AND OTHER BORROW

LONG-TERM DEBT AND OTHER BORROWINGS	6 Months Ended
	Dec. 29, 2019
Debt Disclosure [Abstract]
LONG-TERM DEBT AND OTHER BORROWINGS	LONG-TERM DEBT AND OTHER BORROWINGS As of December 29, 2019 , and June 30, 2019 , the Company’s outstanding debt consisted of the following: December 29, 2019 June 30, 2019 Amount Effective Interest Rate Amount Effective Interest Rate Fixed-rate 2.75% Senior Notes Due March 15, 2020 ("2020 Notes") $ 500,000 2.88 % $ 500,000 2.88 % Fixed-rate 2.80% Senior Notes Due June 15, 2021 ("2021 Notes") 800,000 2.95 % 800,000 2.95 % Fixed-rate 3.80% Senior Notes Due March 15, 2025 ("2025 Notes") 500,000 3.87 % 500,000 3.87 % Fixed-rate 3.75% Senior Notes Due March 15, 2026 ("2026 Notes") 750,000 3.86 % 750,000 3.86 % Fixed-rate 4.00% Senior Notes Due March 15, 2029 ("2029 Notes") 1,000,000 4.09 % 1,000,000 4.09 % Fixed-rate 2.625% Convertible Notes Due May 15, 2041 ("2041 Notes") 167,091 (1) 4.28 % 212,349 (1) 4.28 % Fixed-rate 4.875% Senior Notes Due March 15, 2049 ("2049 Notes") 750,000 4.93 % 750,000 4.93 % Total debt outstanding, at par 4,467,091 4,512,349 Unamortized discount (60,332 ) (73,191 ) Fair value adjustment - interest rate contracts 1,300 (2) (3,612 ) Unamortized bond issuance costs (5,096 ) (5,535 ) Total debt outstanding, at carrying value $ 4,402,963 $ 4,430,011 Reported as: Current portion of long-term debt, and commercial paper $ 628,614 $ 662,308 Long-term debt 3,774,349 3,767,703 Total debt outstanding, at carrying value $ 4,402,963 $ 4,430,011 ____________________________ (1) As of the report date, these notes were convertible at the option of the bondholder. This is a result of the following condition being met: the market value of the Company’s Common Stock was greater than 130% of the convertible notes conversion price for 20 or more of the 30 consecutive trading days preceding the quarter-end. As a result, the 2041 Notes were classified in current liabilities and a portion of the equity component, associated with the convertible notes representing the unamortized discount, was classified in temporary equity on the Company’s Consolidated Balance Sheets. Upon closure of the conversion period, the notes not converted will be reclassified back into noncurrent liabilities and the temporary equity will be reclassified into permanent equity. (2) This amount includes a cumulative fair market gain of $2.8 million for discontinued hedging relationships, net of an immaterial amount of amortization for the three and six months ended December 29, 2019 . Convertible Senior Notes In June 2012, with the acquisition of Novellus Systems, Inc., the Company assumed $700 million in aggregate principal amount of 2.625% Convertible Senior Notes due May 15, 2041 (the “2041 Notes”). The Company pays cash interest at an annual rate of 2.625% , on a semi-annual basis on May 15 and November 15 of each year. The 2041 Notes also have a contingent interest payment provision that may require the Company to pay additional interest, up to 0.60% per year, based on certain thresholds, beginning with the semi-annual interest payment on May 15, 2021, and upon the occurrence of certain events, as outlined in the indenture governing the 2041 Notes. The Company separately accounts for the liability and equity components of the 2041 Notes. The initial debt components of the 2041 Notes were valued based on the present value of the future cash flows using the Company’s borrowing rate at the date of the issuance or assumption for similar debt instruments without the conversion feature, which equals the effective interest rate on the liability component disclosed in the table below, respectively. The equity component was initially valued equal to the principal value of the notes, less the present value of the future cash flows using the Company’s borrowing rate at the date of the issuance or assumption for similar debt instruments without a conversion feature, which equated to the initial debt discount. The 2041 Notes may be redeemed on or after May 21, 2021 at a price equal to outstanding principal plus accrued and unpaid interest if the last reported sales price of common shares has been equal to or more than 150% of the then applicable conversion price for at least 20 trading days during the 30 consecutive trading days prior to the redemption notice date. Under certain circumstances, the 2041 Notes may be converted into shares of the Company’s Common Stock. The number of shares each debenture is convertible into is based on conversion rates, disclosed in the table below. The principal value of the 2041 Note conversions in the three and six months ended December 29, 2019 , was approximately $17.2 million and $45.3 million , respectively. During the quarter ended December 29, 2019 and in the subsequent period through February 3, 2020, the Company received notice of conversion for an additional $116.6 million principal value of 2041 Notes, which will settle in the quarter ending March 29, 2020. Selected additional information regarding the 2041 Notes outstanding as of December 29, 2019 , and June 30, 2019 , is as follows: December 29, June 30, 2041 Notes 2041 Notes (in thousands, except years, percentages, conversion rate, and conversion price) Carrying amount of permanent equity component, net of tax $ 161,271 $ 160,604 Carrying amount of temporary equity component, net of tax $ 38,304 $ 49,439 Remaining amortization period (years) 21.4 21.9 Fair Value of Notes (Level 2) $ 1,532,188 Conversion rate (shares of common stock per $1,000 principal amount of notes) 31.2089 Conversion price (per share of common stock) $ 32.04 If-converted value in excess of par value $ 1,364,475 Estimated share dilution using average quarterly stock price $264.15 per share 4,582 Senior Notes On March 4, 2019, the company completed a public offering of $750 million aggregate principal amount of the Company’s Senior Notes due March 15, 2026 (the “2026 Notes”), $1.0 billion aggregate principal amount of the Company’s Senior Notes due March 15, 2029 (the “2029 Notes”), and $750 million aggregate principal amount of the Company’s Senior Notes due March 15, 2049 (the “2049 Notes”). The Company pays interest at an annual rate of 3.75% , 4.00% , and 4.875% , on the 2026, 2029, and 2049 Notes, respectively, on a semi-annual basis on March 15 and September 15 of each year. On March 12, 2015, the Company completed a public offering of $500 million aggregate principal amount of the Company’s Senior Notes due March 15, 2020 (the “2020 Notes”) and $500 million aggregate principal amount of the Company’s Senior Notes due March 15, 2025 (the “2025 Notes”). The Company pays interest at an annual rate of 2.75% and 3.80% on the 2020 Notes and 2025 Notes, respectively, on a semi-annual basis on March 15 and September 15 of each year. During the year ended June 26, 2016, the Company entered into a series of interest rate contracts hedging the fair value of a portion of the 2025 Notes par value, whereby the Company receives a fixed rate and pays a variable rate based on a certain benchmark interest rate. Refer to Note 8 - Financial Instruments for additional information regarding these interest rate contracts. On June 7, 2016, the Company completed a public offering of $800 million aggregate principal amount of Senior Notes due June 2021 (the “2021 Notes”). The Company pays interest at an annual rate of 2.80% on the 2021 Notes on a semi-annual basis on June 15 and December 15 of each year. The Company may redeem the 2020, 2021, 2025, 2026, 2029 and 2049 Notes (collectively the “Senior Notes”) at a redemption price equal to 100% of the principal amount of such series (“par”), plus a “make whole” premium as described in the indenture in respect to the Senior Notes and accrued and unpaid interest before February 15, 2020 , for the 2020 Notes, before May 15, 2021 for the 2021 Notes, before December 15, 2024 for the 2025 Notes, before January 15, 2026 for the 2026 Notes, before December 15, 2028 for the 2029 Notes, and before September 15, 2048 for the 2049 Notes. In addition, upon the occurrence of certain events, as described in the indenture, the Company will be required to make an offer to repurchase the Senior Notes at a price equal to 101% of the principal amount of the respective note, plus accrued and unpaid interest. Selected additional information regarding the Senior Notes outstanding as of December 29, 2019 , is as follows: Remaining Amortization period Fair Value of Notes (Level 2) (years) (in thousands) 2020 Notes 0.2 $ 500,410 2021 Notes 1.5 $ 809,552 2025 Notes 5.2 $ 536,190 2026 Notes 6.2 $ 805,748 2029 Notes 9.2 $ 1,104,060 2049 Notes 29.2 $ 947,325 Commercial Paper Program On November 13, 2017, the Company established a commercial paper program (“the CP Program”) under which the Company may issue unsecured commercial paper notes on a private placement basis up to a maximum aggregate principal amount of $1.25 billion . The net proceeds from the commercial paper program will be used for general corporate purposes, including repurchases of the Company’s Common Stock from time to time under the Company’s stock repurchase program. Amounts available under the CP Program may be re-borrowed. The CP Program is backstopped by the Company’s Revolving Credit Arrangement. As of December 29, 2019 and June 30, 2019, the Company had no outstanding borrowings under the CP Program. Revolving Credit Facility On March 12, 2014, the Company established an unsecured Credit Agreement. This agreement was amended on November 10, 2015 (the “Amended and Restated Credit Agreement”), October 13, 2017 (the “2nd Amendment”), and February 25, 2019 (the “3rd Amendment”). Under the Amended and Restated Credit Agreement (as amended by the 2nd and 3rd Amendment), the Company has a revolving credit facility of $1.25 billion with a syndicate of lenders with an expansion option that will allow the Company, subject to certain requirements, to request an increase in the facility of up to an additional $600.0 million , for a potential total commitment of $1.85 billion . The facility matures on October 13, 2022. Interest on amounts borrowed under the credit facility is, at the Company’s option, based on (1) a base rate, defined as the greatest of (a) prime rate, (b) Federal Funds rate plus 0.5% , or (c) one-month LIBOR plus 1.0% , plus a spread of 0.0% to 0.5% , or (2) LIBOR multiplied by the statutory rate, plus a spread of 0.9% to 1.50% , in each case as the applicable spread is determined based on the rating of the Company’s non-credit enhanced, senior unsecured long-term debt. Principal and any accrued and unpaid interest is due and payable upon maturity. Additionally, the Company will pay the lenders a quarterly commitment fee that varies based on the Company’s credit rating. The Amended and Restated Credit Agreement contains affirmative covenants, negative covenants, financial covenants and events of default. As of December 29, 2019 , the Company had no borrowings outstanding under the credit facility and was in compliance with all financial covenants. Interest Cost The following table presents the amount of interest cost recognized relating to both the contractual interest coupon and amortization of the debt discount, issuance costs, and effective portion of interest rate contracts with respect to the Senior Notes, convertible notes, the term loan agreement, commercial paper, and the revolving credit facility during the three and six months ended December 29, 2019 and December 23, 2018 . Three Months Ended Six Months Ended December 29, December 23, December 29, December 23, (in thousands) Contractual interest coupon $ 40,665 $ 16,550 $ 81,787 $ 33,977 Amortization of interest discount 1,158 887 2,393 1,787 Amortization of issuance costs 416 329 830 658 Effect of interest rate contracts, net 155 777 830 1,530 Total interest cost recognized $ 42,394 $ 18,543 $ 85,840 $ 37,952

LEASES

LEASES	6 Months Ended
	Dec. 29, 2019
Leases [Abstract]
LEASES	LEASES The Company leases certain office spaces, manufacturing and warehouse spaces, equipment, and vehicles. On July 1, 2019 the Company adopted ASC 842. Refer to Note 2 - Recent Accounting Pronouncements for additional information regarding the adoption. While the majority of the Company’s lease arrangements are operating leases, the Company has certain leases that qualify as finance leases. Lease accounting policy Lease expense for operating leases is recognized on a straight-line basis over the lease term. The Company includes renewals and terminations in the calculation of the right-of-use asset and liability when the provision is reasonably certain to be exercised. The Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of future lease payments when the rate implicit in the lease is unknown. The Company has elected the following practical expedients and accounting policy elections for accounting under ASC 842: (i) leases with an initial lease term of 12 months or less are not recorded on the balance sheet; and (ii) lease and non-lease components of a contract are accounted for as a single lease component. Lease details The components of lease expense were as follows: Three Months Ended Six Months Ended December 29, December 29, (in thousands) Financing lease cost: Amortization of right-of-use assets $ 891 $ 1,819 Interest on lease liabilities 115 265 Total finance lease cost $ 1,006 $ 2,084 Operating lease cost $ 10,421 $ 21,185 Variable lease cost 22,071 41,018 Variable lease payments are expensed as incurred and are not included within the right of use asset and lease liability calculation. Variable lease payments primarily include costs associated with the Company’s third party logistics arrangements that contain one or more embedded leases. Variable lease costs will fluctuate based on factory output and material receipt volumes. Short-term rental expense, for agreements less than one year in duration, were immaterial for the three and six months ended December 29, 2019 . Supplemental cash flow information related to leases was as follows: Six Months Ended December 29, 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows paid for operating leases $ 19,384 Financing cash flows paid for principal portion of finance leases 1,647 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 11,968 Finance leases 1,357 Supplemental balance sheet information related to leases were as follows: December 29, 2019 (in thousands) Operating leases Other assets $ 101,605 Accrued expenses and other current liabilities $ 36,480 Other long-term liabilities 70,442 Total operating lease liabilities $ 106,922 Finance Leases Property and Equipment, net $ 18,684 Current portion of long-term debt and lease liabilities $ 3,677 Long-term debt and lease liabilities 11,719 Total finance lease liabilities $ 15,396 December 29, 2019 Weighted-Average Remaining Lease Term Weighted-Average Discount Rate (in years) Operating leases 4.4 2.57 % Finance leases 4.3 2.82 % As of December 29, 2019 , the maturities of lease liabilities are as follows: Fiscal Year Operating Leases Finance Leases (in thousands) 2020 (remaining 6 months) $ 19,237 $ 2,022 2021 34,265 3,548 2022 18,256 6,208 2023 11,659 1,200 2024 8,591 841 Thereafter 20,809 2,920 Total lease payments $ 112,817 $ 16,739 Less imputed interest (5,895 ) (1,343 ) Total $ 106,922 $ 15,396 Selected Operating Leases and Related Guarantees The Company leases the majority of its administrative, research and development and manufacturing facilities, regional sales/service offices, and certain equipment under non-cancelable operating leases. Certain of the Company’s facility leases for buildings located at its Fremont, California headquarters, Tualatin, Oregon campus, and certain other facility leases provide the Company with options to extend the leases for additional periods or to purchase the facilities. Certain of the Company’s facility leases provide for periodic rent increases based on the general rate of inflation. The Company has operating leases regarding certain improved properties in Fremont and Livermore, California (the “California Operating Leases”). The Company is required to maintain cash collateral in an aggregate of approximately $250.0 million in separate interest-bearing accounts as security for the Company’s obligations. These amounts are recorded with other restricted cash and investments in the Company’s Condensed Consolidated Balance Sheet as of December 29, 2019 . During the term of the California Operating Leases and when the terms of the California Operating Leases expire, the property subject to the California Operating Leases may be re-marketed. The Company has guaranteed to the lessor that each property will have a certain minimum residual value. The aggregate guarantee made by the Company under the California Operating Leases is generally no more than $220.4 million ; however, under certain default circumstances, the guarantee with regard to the California Operating Lease may be 100% of the lessor’s aggregate investment in the applicable property, which in no case will exceed $250.0 million , in the aggregate.
LEASES	LEASES The Company leases certain office spaces, manufacturing and warehouse spaces, equipment, and vehicles. On July 1, 2019 the Company adopted ASC 842. Refer to Note 2 - Recent Accounting Pronouncements for additional information regarding the adoption. While the majority of the Company’s lease arrangements are operating leases, the Company has certain leases that qualify as finance leases. Lease accounting policy Lease expense for operating leases is recognized on a straight-line basis over the lease term. The Company includes renewals and terminations in the calculation of the right-of-use asset and liability when the provision is reasonably certain to be exercised. The Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of future lease payments when the rate implicit in the lease is unknown. The Company has elected the following practical expedients and accounting policy elections for accounting under ASC 842: (i) leases with an initial lease term of 12 months or less are not recorded on the balance sheet; and (ii) lease and non-lease components of a contract are accounted for as a single lease component. Lease details The components of lease expense were as follows: Three Months Ended Six Months Ended December 29, December 29, (in thousands) Financing lease cost: Amortization of right-of-use assets $ 891 $ 1,819 Interest on lease liabilities 115 265 Total finance lease cost $ 1,006 $ 2,084 Operating lease cost $ 10,421 $ 21,185 Variable lease cost 22,071 41,018 Variable lease payments are expensed as incurred and are not included within the right of use asset and lease liability calculation. Variable lease payments primarily include costs associated with the Company’s third party logistics arrangements that contain one or more embedded leases. Variable lease costs will fluctuate based on factory output and material receipt volumes. Short-term rental expense, for agreements less than one year in duration, were immaterial for the three and six months ended December 29, 2019 . Supplemental cash flow information related to leases was as follows: Six Months Ended December 29, 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows paid for operating leases $ 19,384 Financing cash flows paid for principal portion of finance leases 1,647 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 11,968 Finance leases 1,357 Supplemental balance sheet information related to leases were as follows: December 29, 2019 (in thousands) Operating leases Other assets $ 101,605 Accrued expenses and other current liabilities $ 36,480 Other long-term liabilities 70,442 Total operating lease liabilities $ 106,922 Finance Leases Property and Equipment, net $ 18,684 Current portion of long-term debt and lease liabilities $ 3,677 Long-term debt and lease liabilities 11,719 Total finance lease liabilities $ 15,396 December 29, 2019 Weighted-Average Remaining Lease Term Weighted-Average Discount Rate (in years) Operating leases 4.4 2.57 % Finance leases 4.3 2.82 % As of December 29, 2019 , the maturities of lease liabilities are as follows: Fiscal Year Operating Leases Finance Leases (in thousands) 2020 (remaining 6 months) $ 19,237 $ 2,022 2021 34,265 3,548 2022 18,256 6,208 2023 11,659 1,200 2024 8,591 841 Thereafter 20,809 2,920 Total lease payments $ 112,817 $ 16,739 Less imputed interest (5,895 ) (1,343 ) Total $ 106,922 $ 15,396 Selected Operating Leases and Related Guarantees The Company leases the majority of its administrative, research and development and manufacturing facilities, regional sales/service offices, and certain equipment under non-cancelable operating leases. Certain of the Company’s facility leases for buildings located at its Fremont, California headquarters, Tualatin, Oregon campus, and certain other facility leases provide the Company with options to extend the leases for additional periods or to purchase the facilities. Certain of the Company’s facility leases provide for periodic rent increases based on the general rate of inflation. The Company has operating leases regarding certain improved properties in Fremont and Livermore, California (the “California Operating Leases”). The Company is required to maintain cash collateral in an aggregate of approximately $250.0 million in separate interest-bearing accounts as security for the Company’s obligations. These amounts are recorded with other restricted cash and investments in the Company’s Condensed Consolidated Balance Sheet as of December 29, 2019 . During the term of the California Operating Leases and when the terms of the California Operating Leases expire, the property subject to the California Operating Leases may be re-marketed. The Company has guaranteed to the lessor that each property will have a certain minimum residual value. The aggregate guarantee made by the Company under the California Operating Leases is generally no more than $220.4 million ; however, under certain default circumstances, the guarantee with regard to the California Operating Lease may be 100% of the lessor’s aggregate investment in the applicable property, which in no case will exceed $250.0 million , in the aggregate.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Dec. 29, 2019
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES Refer to Note 13 - Leases for details regarding guarantees surrounding selected operating leases. Other Guarantees The Company has issued certain indemnifications to its lessors for taxes and general liability under some of its agreements. The Company has entered into insurance contracts that are intended to limit its exposure to such indemnifications. As of December 29, 2019 , the Company had not recorded any liability on its Condensed Consolidated Financial Statements in connection with these indemnifications, as it does not believe that it is probable that any material amounts will be paid under these guarantees. Generally, the Company indemnifies, under pre-determined conditions and limitations, its customers for infringement of third-party intellectual property rights by the Company’s products or services. The Company seeks to limit its liability for such indemnity to an amount not to exceed the sales price of the products or services subject to its indemnification obligations. The Company does not believe that it is probable that any material amounts will be paid under these guarantees. The Company provides guarantees and standby letters of credit to certain parties as required for certain transactions initiated during the ordinary course of business. As of December 29, 2019 , the maximum potential amount of future payments that the Company could be required to make under these arrangements and letters of credit was $58.4 million . The Company does not believe, based on historical experience and information currently available, that it is probable that any material amounts will be required to be paid. In addition, the Company has entered into indemnification agreements with its officers and directors, consistent with its Bylaws and Certificate of Incorporation; and under local law, the Company may be required to provide indemnification to its employees for actions within the scope of their employment. Although the Company maintains insurance contracts that cover some of the potential liability associated with these indemnification agreements, there is no guarantee that all such liabilities will be covered. The Company does not believe, based on historical experience and information currently available, that it is probable that any material amounts will be required to be paid under such indemnification agreements or statutory obligations. Warranties The Company provides standard warranties on its systems. The liability amount is based on actual historical warranty spending activity by type of system, customer, and geographic region, modified for any known differences such as the impact of system reliability improvements. Changes in the Company’s product warranty reserves were as follows: Three Months Ended Six Months Ended December 29, December 23, December 29, December 23, (in thousands) Balance at beginning of period $ 114,470 $ 157,363 $ 127,932 $ 169,407 Warranties issued during the period 40,419 36,853 70,899 72,793 Settlements made during the period (31,848 ) (44,199 ) (66,916 ) (89,506 ) Changes in liability for pre-existing warranties (4,848 ) (2,262 ) (13,722 ) (4,939 ) Balance at end of period $ 118,193 $ 147,755 $ 118,193 $ 147,755 Legal Proceedings While the Company is not currently a party to any legal proceedings that it believes material, the Company is either a defendant or plaintiff in various actions that have arisen from time to time in the normal course of business, including intellectual property claims. The Company accrues for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable. Based on current information, the Company does not believe that a material loss from known matters is probable and therefore has not recorded an accrual of any material amount for litigation or other contingencies related to existing legal proceedings.

STOCK REPURCHASE PROGRAM

STOCK REPURCHASE PROGRAM	6 Months Ended
	Dec. 29, 2019
Equity [Abstract]
STOCK REPURCHASE PROGRAM	STOCK REPURCHASE PROGRAM In November 2018, the Board of Directors authorized the Company to repurchase up to an additional $5.0 billion of Common Stock. These repurchases can be conducted on the open market or as private purchases and may include the use of derivative contracts with large financial institutions, in all cases subject to compliance with applicable law. This repurchase program has no termination date and may be suspended or discontinued at any time. Funding for this repurchase program may be through a combination of cash on hand, cash generation, and borrowings. As of December 29, 2019 , the Company has purchased approximately $3.0 billion of shares under this authorization, comprised of $0.5 billion of open market purchases and execution of $2.5 billion of accelerated share repurchase arrangements. Repurchases under the repurchase program were as follows during the periods indicated: Period Total Number of Total Cost of Average Price (1) Amount (in thousands, except per share data) Available balance as of June 30, 2019 $ 3,033,500 Quarter ended September 29, 2019 383 $ 75,196 $ 196.34 $ 2,958,304 Quarter ended December 29, 2019 3,224 $ 1,000,475 $ — $ 1,957,829 (1) Average price paid per share excludes the effect of accelerated share repurchases. See additional disclosure below regarding the Company’s accelerated share repurchase activity during the six months ended December 29, 2019. In addition to the shares repurchased under the Board-authorized repurchase program shown above, during the three and six months ended December 29, 2019 , the Company acquired 18 thousand shares at a total cost of $4.9 million and 32 thousand shares at a total cost of $7.8 million , respectively, which the Company withheld through net settlements to cover minimum tax withholding obligations upon the vesting of restricted stock unit awards granted under the Company’s equity compensation plans. The shares retained by the Company through these net share settlements are not a part of the Board-authorized repurchase program but instead are authorized under the Company’s equity compensation plan. Accelerated Share Repurchase Agreements On November 22, 2019, the Company entered into two separate accelerated share repurchase agreements (collectively, the "November 2019 ASR") with two financial institutions to repurchase a total of $1.0 billion of Common Stock. The Company took an initial delivery of approximately 2.9 million shares, which represented 75% of the prepayment amount divided by the Company’s closing stock price on November 22, 2019. The total number of shares received under the November 2019 ASR will be based upon the average daily volume weighted average price of the Company’s Common Stock during the repurchase period, less an agreed upon discount. Final settlement of the November 2019 ASR will occur no later than May 27, 2020. On June 4, 2019, the Company entered into four separate accelerated share repurchase agreements (collectively, the "June 2019 ASR") with two financial institutions to repurchase a total of $750 million of Common Stock. The Company took an initial delivery of approximately 3.1 million shares, which represented 75% of the prepayment amount divided by the Company’s closing stock price on June 4, 2019. The total number of shares received under the June 2019 ASR was based upon the average daily volume weighted average price of the Company’s Common Stock during the repurchase period, less an agreed upon discount. Final settlement of the agreements occurred during November 2019, resulting in the receipt of approximately 361 thousand additional shares, which yielded a weighted-average share price of approximately $215.60 for the transaction period.

ACCUMULATED OTHER COMPREHENSIVE

ACCUMULATED OTHER COMPREHENSIVE LOSS	6 Months Ended
	Dec. 29, 2019
Equity [Abstract]
ACCUMULATED OTHER COMPREHENSIVE LOSS	ACCUMULATED OTHER COMPREHENSIVE LOSS The components of accumulated other comprehensive income (loss), net of tax at December 29, 2019 , as well as the activity for the six months ending December 29, 2019 , were as follows: Accumulated Foreign Currency Translation Adjustment Accumulated Accumulated Accumulated Total (in thousands) Balance at June 30, 2019 $ (39,370 ) $ (4,330 ) $ 2,146 $ (22,476 ) $ (64,030 ) Other comprehensive (loss) income before reclassifications (1,174 ) 3,388 (2,713 ) 578 79 (Gains) losses reclassified from accumulated other comprehensive income (loss) to net income (13 ) 2,734 (1) 983 (2) — 3,704 Net current-period other comprehensive (loss) income (1,187 ) 6,122 (1,730 ) 578 3,783 Balance at December 29, 2019 $ (40,557 ) $ 1,792 $ 416 $ (21,898 ) $ (60,247 ) (1) Amount of after tax loss reclassified from AOCI into net income located in revenue: $0.4 million loss; cost of goods sold: $1.6 million loss; and selling, general, and administrative expenses: $0.7 million loss. (2) Amount of after tax loss reclassified from accumulated other comprehensive income into net income located in other expense, net.

BASIS OF PRESENTATION (Policies

BASIS OF PRESENTATION (Policies)	6 Months Ended
	Dec. 29, 2019
Accounting Policies [Abstract]
Consolidation	The condensed consolidated financial statements include the accounts of Lam Research and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
Fiscal Period	The Company’s reporting period is a 52/53-week fiscal year. The Company’s current fiscal year will end June 28, 2020 and includes 52
Recent Accounting Pronouncements	Recently Adopted In February 2016, the FASB issued ASU 2016-02, “Leases.” The amendment establishes the principles that lessees and lessors shall apply to report useful information to users of financial statements about the amount, timing, and uncertainty of cash flows arising from a lease. In January 2018 and July 2018 the FASB issued ASU 2018-01 and ASU 2018-11 amending the effects of ASU 2016-02, which in combination with ASU 2016-02 were codified as Accounting Standard Codification topic 842 (“ASC 842”). The Company adopted ASC 842 on the first day of the current fiscal year, July 1, 2019, under the modified-retrospective approach, applying the amendments to prospective reporting periods. Results for reporting periods beginning on or after July 1, 2019 are presented under ASC 842, while prior period amounts are not adjusted and continue to be reported in accordance with the historic accounting under ASC 840. The Company elected the package of practical expedients that allowed the Company not to reassess (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct lease costs for existing leases. The Company did not elect to use hindsight in connection with the adoption of ASC 842. The Company adopted ASC 842 by recording operating right-of-use assets of $110.8 million , net of deferred rent liabilities of $3.0 million that were reclassified to operating right-of-use assets, and operating lease liabilities of $113.8 million . The Company also recognized an adjustment of $3.0 million to retained earnings, net of tax; a reduction of $40.4 million to property and equipment, net; and a reduction of $43.8 million to finance leases ( $42.3 million of which was previously recognized in long-term debt and finance lease obligations, less current portion and the remaining was previously recognized in current portion of long-term debt and finance lease obligations) related to its de-recognition of its previously recorded build-to-suit arrangements. The adoption of the standard did not materially impact the Company’s Condensed Consolidated Statement of Operations and had no impact on cash flows. Updates Not Yet Effective In June 2016, the FASB released ASU 2016-13, “Financial Instruments – Credit Losses.” The amendment revises the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in more timely recognition of losses on financial instruments, including but not limited to, available for sale debt securities and accounts receivable. The FASB issued a subsequent amendment to the initial guidance in November 2019 within ASU 2019-11. The Company is required to adopt these amendments starting in the first quarter of fiscal year 2021 using a modified-retrospective approach. Early adoption is permitted. The Company is still evaluating the impact of this standard, but does not expect the adoption to have a material impact on its Condensed Consolidated Financial Statements. In November 2018, the FASB issued ASU 2018-18, "Collaborative Arrangements (Topic 808).” The amendment clarifies that certain transactions between participants in a collaborative arrangement should be accounted for under Topic 606 when the counterparty is a customer for a good or service that is a distinct unit of account. The amendment also precludes entities from presenting consideration from transactions with a collaborator that is not a customer together with revenue recognized from contracts with customers. The Company is required to adopt this standard starting in the first quarter of fiscal year 2021. The standard should be applied retrospectively to the period when the Company initially adopted ASC 606. The Company is currently evaluating the impact of adoptions on its Condensed Consolidated Financial Statements. In April 2019, the FASB issued ASU 2019-04,”Codification Improvements to Topic 326, Financial Instruments-Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments ”, that clarifies and improves areas of guidance related to the recently issued standards on credit losses (ASU 2016-13), hedging (ASU 2017-12), and recognition and measurement of financial instruments (ASU 2016-01). The amendments generally have the same effective dates as their related standards. If already adopted, the amendments of ASU 2016-01 and ASU 2016-13 are effective starting in the first quarter of fiscal year 2021. The amendments of ASU 2017-12 were effective in the first quarter of fiscal year 2020, and did not have a material impact on the Company’s Condensed Consolidated Financial Statements. The Company continues to evaluate the impact of ASU 2016-13 and will consider the amendments of ASU 2019-04 as part of that process.
Inventories	Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. System shipments to customers in Japan, for which title does not transfer until customer acceptance, are classified as finished goods inventory and carried at cost until title transfers.
Warranties	The Company provides standard warranties on its systems. The liability amount is based on actual historical warranty spending activity by type of system, customer, and geographic region, modified for any known differences such as the impact of system reliability improvements.

REVENUE (Tables)

REVENUE (Tables)	6 Months Ended
	Dec. 29, 2019
Revenue from Contract with Customer [Abstract]
Summary of Contract Transaction Price not yet Recognized as Revenue	The following table summarizes the transaction price for contracts that have not yet been recognized as revenue as of December 29, 2019 and when the Company expects to recognize the amounts as revenue: Less than 1 Year 1-3 Years More than 3 Years Total (In thousands) Deferred revenue $ 372,927 $ 37,834 (1) $ — $ 410,761 (1) This amount is reported in Deferred profit on the Company's Condensed Consolidated Balance Sheets as the customers can demand the liability to be performed at any time.
Disaggregation of Revenue	The following table presents the Company’s revenues disaggregated by geographic region: Three Months Ended Six Months Ended December 29, December 23, December 29, December 23, (In thousands) China $ 758,286 $ 361,782 $ 1,349,954 $ 955,613 Taiwan 680,871 425,533 1,072,363 705,583 Korea 463,178 631,502 914,661 1,011,272 United States 223,725 135,696 407,384 255,801 Japan 208,240 691,817 481,913 1,361,857 Southeast Asia 184,168 165,204 397,923 363,340 Europe 65,033 111,139 125,049 199,898 $ 2,583,501 $ 2,522,673 $ 4,749,247 $ 4,853,364
Schedule of System Revenues of Primary Markets	The following table presents the percentages of system revenues to each of the primary markets we serve: Three Months Ended Six Months Ended December 29, December 23, December 29, December 23, Memory 52 % 79 % 58 % 78 % Foundry 36 % 13 % 31 % 15 % Logic/integrated device manufacturing 12 % 8 % 11 % 7 %

EQUITY-BASED COMPENSATION PLA_2

EQUITY-BASED COMPENSATION PLANS (Tables)	6 Months Ended
	Dec. 29, 2019
Share-based Payment Arrangement [Abstract]
Recognized Equity Based Compensation Expense and Related Income Tax Benefit	The Company recognized the following equity-based compensation expense (including expense related to the employee stock purchase plan) and related income tax benefit in the Condensed Consolidated Statements of Operations: Three Months Ended Six Months Ended December 29, December 23, December 29, December 23, (in thousands) Equity-based compensation expense $ 45,725 $ 38,806 $ 88,630 $ 89,149 Income tax benefit recognized related to equity-based compensation expense $ 4,461 $ 5,763 $ 14,279 $ 13,867

OTHER EXPENSE, NET (Tables)

OTHER EXPENSE, NET (Tables)	6 Months Ended
	Dec. 29, 2019
Other Income and Expenses [Abstract]
Components of Other Expense, Net	The significant components of other expense, net, are as follows: Three Months Ended Six Months Ended December 29, December 23, December 29, December 23, (in thousands) Interest income $ 25,454 $ 17,809 $ 57,238 $ 36,742 Interest expense (42,615 ) (19,784 ) (86,610 ) (41,572 ) Gains (losses) on deferred compensation plan-related assets, net 14,129 (22,374 ) 13,693 (17,160 ) Foreign exchange (losses) gains, net (2,287 ) 2,581 (2,816 ) 2,632 Other, net (8,605 ) (8,881 ) (8,157 ) (11,668 ) $ (13,924 ) $ (30,649 ) $ (26,652 ) $ (31,026 )

NET INCOME PER SHARE (Tables)

NET INCOME PER SHARE (Tables)	6 Months Ended
	Dec. 29, 2019
Earnings Per Share [Abstract]
Schedule of Numerators and Denominators of Basic and Diluted Computations for Net Income Per Share	The following table reconciles the numerators and denominators of the basic and diluted computations for net income per share. Three Months Ended Six Months Ended December 29, December 23, December 29, December 23, (in thousands, except per share data) Numerator: Net income $ 514,510 $ 568,855 $ 980,299 $ 1,102,215 Denominator: Basic average shares outstanding 143,987 155,022 144,330 155,340 Effect of potential dilutive securities: Employee stock plans 1,528 1,435 1,359 1,487 Convertible notes 4,582 5,713 4,700 5,894 Warrants — — — 1,028 Diluted average shares outstanding 150,097 162,170 150,389 163,749 Net income per share - basic $ 3.57 $ 3.67 $ 6.79 $ 7.10 Net income per share - diluted $ 3.43 $ 3.51 $ 6.52 $ 6.73
Schedule of Potentially Dilutive Securities Excluded from EPS Calculations	The following potentially dilutive securities were excluded: Three Months Ended Six Months Ended December 29, December 23, December 29, December 23, (in thousands) Options and RSUs 3 227 4 890

FINANCIAL INSTRUMENTS (Tables)

FINANCIAL INSTRUMENTS (Tables)	6 Months Ended
	Dec. 29, 2019
Fair Value Disclosures [Abstract]
Cash, Cash Equivalents, Investments, Restricted Cash and Investments and Other Assets Measured at Fair Value on Recurring Basis	The following table sets forth the Company’s cash, cash equivalents, investments, restricted cash and investments, and other assets measured at fair value on a recurring basis as of December 29, 2019 , and June 30, 2019 : December 29, 2019 (Reported Within) Cost Unrealized Unrealized Fair Value Cash and Investments Restricted Other (in thousands) Cash $ 580,318 $ — $ — $ 580,318 $ 576,439 $ — $ 3,879 $ — Time deposit 1,606,528 — — 1,606,528 1,356,500 — 250,028 — Level 1: Money market funds 977,274 — — 977,274 977,274 — — — U.S. Treasury and agencies 476,406 116 (54 ) 476,468 — 476,468 — — Mutual funds 75,244 5,792 (452 ) 80,584 — — — 80,584 Level 1 Total 1,528,924 5,908 (506 ) 1,534,326 977,274 476,468 — 80,584 Level 2: Government-sponsored enterprises 9,819 — (3 ) 9,816 2,799 7,017 — — Foreign government bonds 30,507 2 (6 ) 30,503 — 30,503 — — Corporate notes and bonds 1,225,526 742 (444 ) 1,225,824 122,875 1,102,949 — — Mortgage backed securities — residential 4,172 8 — 4,180 — 4,180 — — Mortgage backed securities — commercial 26,751 34 (35 ) 26,750 — 26,750 — — Level 2 Total 1,296,775 786 (488 ) 1,297,073 125,674 1,171,399 — — Total $ 5,012,545 $ 6,694 $ (994 ) $ 5,018,245 $ 3,035,887 $ 1,647,867 $ 253,907 $ 80,584 June 30, 2019 (Reported Within) Cost Unrealized Unrealized Fair Value Cash and Investments Restricted Other (in thousands) Cash $ 467,460 $ — $ — $ 467,460 $ 462,310 $ — $ 5,150 $ — Time deposit 1,563,686 — — 1,563,686 1,313,659 — 250,027 — Level 1: Money market funds 1,644,659 — — 1,644,659 1,644,659 — — — U.S. Treasury and agencies 465,655 283 (24 ) 465,914 86,981 378,933 — — Mutual funds 76,961 1,063 (283 ) 77,741 — — — 77,741 Level 1 Total 2,187,275 1,346 (307 ) 2,188,314 1,731,640 378,933 — 77,741 Level 2: Government-sponsored enterprises 16,005 5 (41 ) 15,969 — 15,969 — — Foreign government bonds 24,408 35 — 24,443 — 24,443 — — Corporate notes and bonds 1,466,167 2,310 (99 ) 1,468,378 150,610 1,317,768 — — Mortgage backed securities — residential 6,148 — (4 ) 6,144 — 6,144 — — Mortgage backed securities — commercial 29,587 140 — 29,727 — 29,727 — — Level 2 Total 1,542,315 2,490 (144 ) 1,544,661 150,610 1,394,051 — — Total $ 5,760,736 $ 3,836 $ (451 ) $ 5,764,121 $ 3,658,219 $ 1,772,984 $ 255,177 $ 77,741
Schedule of Cash, Cash Equivalents, Investments and Restricted Cash and Investments in Unrealized Loss Positions	The following is an analysis of the Company’s cash, cash equivalents, investments, and restricted cash and investments in unrealized loss positions: December 29, 2019 Unrealized Losses Unrealized Losses Total Fair Value Gross Fair Value Gross Fair Value Gross (in thousands) U.S. Treasury and agencies $ 325,502 $ (54 ) $ — $ — $ 325,502 $ (54 ) Mutual funds 2,925 (195 ) 7,955 (257 ) 10,880 (452 ) Government-sponsored enterprises — — 6,995 (3 ) 6,995 (3 ) Foreign government bonds 29,420 (6 ) — — 29,420 (6 ) Corporate notes and bonds 703,002 (441 ) 6,780 (3 ) 709,782 (444 ) Mortgage backed securities — commercial 16,805 (35 ) — — 16,805 (35 ) $ 1,077,654 $ (731 ) $ 21,730 $ (263 ) $ 1,099,384 $ (994 )
Schedule of Amortized Cost and Fair Value of Cash Equivalents, Investments, Restricted Cash and Investments with Contractual Maturities	The amortized cost and fair value of cash equivalents, investments, and restricted investments with contractual maturities are as follows as of December 29, 2019 : Cost Estimated (in thousands) Due in one year or less $ 3,889,431 $ 3,889,377 Due after one year through five years 444,558 444,950 Due in more than five years 22,994 23,016 $ 4,356,983 $ 4,357,343
Schedule of Outstanding Foreign Currency Forward Contracts	As of December 29, 2019 , the Company had the following outstanding foreign currency contracts that were entered into under its cash flow and balance sheet hedge programs: Notional Value Derivatives Designated as Derivatives Not Designated (in thousands) Foreign currency forward contracts Buy Contracts Sell Contracts Buy Contracts Sell Contracts Japanese yen $ — $ 100,830 $ 61,301 $ — Euro 61,007 — 42,371 — Korean won 15,401 — — 4,294 British pound sterling — — 48,439 — Taiwan dollar — — 33,328 — Chinese renminbi — — 31,683 — Swiss franc — — 22,493 — Singapore dollar — — 21,409 — Indian rupee — — 7,855 — $ 76,408 $ 100,830 $ 268,879 $ 4,294
Schedule of Fair Value of Derivatives Instruments	The fair value of derivative instruments in the Company’s Condensed Consolidated Balance Sheet as of December 29, 2019 , and June 30, 2019 were as follows: December 29, 2019 June 30, 2019 Fair Value of Derivative Instruments (Level 2) Fair Value of Derivative Instruments (Level 2) Derivative Assets Derivative Liabilities Derivative Assets Derivative Liabilities Balance Sheet Fair Value Balance Sheet Fair Value Balance Sheet Fair Value Balance Sheet Fair Value (in thousands) Derivatives designated as hedging instruments: Foreign exchange contracts Prepaid expense $ 2,437 Accrued expenses and other current liabilities $ 16 Prepaid expense $ 119 Accrued expenses and other current liabilities $ 2,756 Interest rate contracts, short-term — Accrued expenses and other current liabilities 2,746 — Accrued expenses and other current liabilities 5,149 Interest rate contracts, long-term Other assets 3,605 — Other assets 1,537 — Derivatives not designated as hedging instruments: Foreign exchange contracts Prepaid expense 21 Accrued expenses and other current liabilities 200 Prepaid expense 1,249 Accrued expenses and other current liabilities 748 Total Derivatives $ 6,063 $ 2,962 $ 2,905 $ 8,653
Schedule of Derivative Instruments Designated as Cash Flow Hedges in Statements of Operations	The effect of derivative instruments designated as cash flow hedges on the Company’s Condensed Consolidated Statements of Operations, including accumulated other comprehensive income (“AOCI”) was as follows: Three Months Ended Six Months Ended December 29, 2019 December 29, 2019 Location of Gain Loss Gain (Loss) Loss Derivatives in Cash Flow Hedging Relationships (in thousands) Foreign Exchange Contracts Revenue $ 2,264 $ (172 ) $ 3,198 $ (506 ) Foreign Exchange Contracts Cost of goods sold 196 (1,090 ) (1,067 ) (1,900 ) Foreign Exchange Contracts Selling, general, and administrative 130 (417 ) (465 ) (893 ) Interest Rate Contracts Other expense, net 2,394 (35 ) 2,394 (70 ) $ 4,984 $ (1,714 ) $ 4,060 $ (3,369 ) Three Months Ended Six Months Ended December 23, 2018 December 23, 2018 Location of Gain (Loss) Gain (Loss) Gain (Loss) Gain (Loss) Derivatives in Cash Flow Hedging Relationships (in thousands) Foreign Exchange Contracts Revenue $ 8,229 $ 7,813 $ 16,670 $ 8,487 Foreign Exchange Contracts Cost of goods sold (1,965 ) (851 ) (2,089 ) (2,408 ) Foreign Exchange Contracts Selling, general, and administrative (674 ) (651 ) (878 ) (1,178 ) Interest Rate Contracts Other expense, net — (33 ) — (66 ) $ 5,590 $ 6,278 $ 13,703 $ 4,835 The effect of derivative instruments not designated as cash flow hedges on the Company’s Condensed Consolidated Statements of Operations was as follows: Three Months Ended Six Months Ended December 29, December 23, December 29, December 23, Derivatives Not Designated as Hedging Instruments: Location Gain Gain Loss Gain (in thousands) Foreign Exchange Contracts Other income $ 3,571 $ 301 $ (1,930 ) $ 10,889 The following table presents the effect of the fair value cash flow hedge accounting on the Statement of Financial Performance as well as presents the location and amount of gain/(loss) recognized in Income on fair value and cash flow hedging relationships: Three Months Ended Six Months Ended December 29, 2019 December 29, 2019 Revenue Cost of Goods Sold Selling, General and Admini-strative Other Income (Expense) Revenue Cost of Goods Sold Selling, General and Admini-strative Other Income (Expense) (in thousands) Total amounts of income and expense line items presented in the statement of financial performance in which the effects of fair value or cash flow hedges are recorded: $ 2,583,501 $1,403,857 $ 174,272 $ (13,924 ) $ 4,749,247 $ 2,587,893 $ 331,700 $ (26,652 ) The effects of fair value and cash flow hedging: Gain or (loss) on fair value hedging relationships in Subtopic 815-20: Interest contracts: Hedged items $ — $ — $ — $ 2,342 $ — $ — $ — $ (5,092 ) Derivatives designated as hedging instruments $ — $ — $ — $ (2,342 ) $ — $ — $ — $ 5,092 Gain or (loss) on cash flow hedging relationships in Subtopic 815-20: Foreign exchange contracts: Amount of loss reclassified from accumulated other comprehensive income into income $ (172 ) $ (1,090 ) $ (417 ) $ — $ (506 ) $ (1,900 ) $ (893 ) $ — Interest rate contracts: Amount of loss reclassified from accumulated other comprehensive income into income $ — $ — $ — $ (35 ) $ — $ — $ — $ (70 )

INVENTORIES (Tables)

INVENTORIES (Tables)	6 Months Ended
	Dec. 29, 2019
Inventory Disclosure [Abstract]
Schedule of Inventories	Inventories consist of the following: December 29, June 30, (in thousands) Raw materials $ 980,751 $ 994,738 Work-in-process 200,626 174,219 Finished goods 347,243 371,183 $ 1,528,620 $ 1,540,140

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS (Tables)	6 Months Ended
	Dec. 29, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	The following table provides the Company’s intangible assets: December 29, 2019 June 30, 2019 Gross Accumulated Net Gross Accumulated Net (in thousands) Customer relationships $ 630,206 $ (508,199 ) $ 122,007 $ 630,165 $ (483,204 ) $ 146,961 Existing technology 669,488 (651,379 ) 18,109 669,399 (647,837 ) 21,562 Patents and other intangible assets 135,048 (82,048 ) 53,000 126,235 (77,808 ) 48,427 Total intangible assets $ 1,434,742 $ (1,241,626 ) $ 193,116 $ 1,425,799 $ (1,208,849 ) $ 216,950
Estimated Future Amortization Expense of Intangible Assets	The estimated future amortization expense of intangible assets as of December 29, 2019 , is reflected in the table below. The table excludes $13.5 million of capitalized costs for intangible assets that have not been placed into service. Fiscal Year Amount (in thousands) 2020 (remaining 6 months) $ 32,742 2021 63,431 2022 59,093 2023 14,025 2024 7,324 Thereafter 2,962 $ 179,577

ACCRUED EXPENSES AND OTHER CU_2

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)	6 Months Ended
	Dec. 29, 2019
Payables and Accruals [Abstract]
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consist of the following: December 29, June 30, (in thousands) Accrued compensation $ 390,033 $ 336,090 Warranty reserves 118,193 127,932 Income and other taxes payable 134,615 49,926 Dividend payable 163,510 158,868 Other 307,662 273,825 $ 1,114,013 $ 946,641

LONG-TERM DEBT AND OTHER BORR_2

LONG-TERM DEBT AND OTHER BORROWINGS (Tables)	6 Months Ended
	Dec. 29, 2019
Debt Disclosure [Abstract]
Schedule of Outstanding Debt	As of December 29, 2019 , and June 30, 2019 , the Company’s outstanding debt consisted of the following: December 29, 2019 June 30, 2019 Amount Effective Interest Rate Amount Effective Interest Rate Fixed-rate 2.75% Senior Notes Due March 15, 2020 ("2020 Notes") $ 500,000 2.88 % $ 500,000 2.88 % Fixed-rate 2.80% Senior Notes Due June 15, 2021 ("2021 Notes") 800,000 2.95 % 800,000 2.95 % Fixed-rate 3.80% Senior Notes Due March 15, 2025 ("2025 Notes") 500,000 3.87 % 500,000 3.87 % Fixed-rate 3.75% Senior Notes Due March 15, 2026 ("2026 Notes") 750,000 3.86 % 750,000 3.86 % Fixed-rate 4.00% Senior Notes Due March 15, 2029 ("2029 Notes") 1,000,000 4.09 % 1,000,000 4.09 % Fixed-rate 2.625% Convertible Notes Due May 15, 2041 ("2041 Notes") 167,091 (1) 4.28 % 212,349 (1) 4.28 % Fixed-rate 4.875% Senior Notes Due March 15, 2049 ("2049 Notes") 750,000 4.93 % 750,000 4.93 % Total debt outstanding, at par 4,467,091 4,512,349 Unamortized discount (60,332 ) (73,191 ) Fair value adjustment - interest rate contracts 1,300 (2) (3,612 ) Unamortized bond issuance costs (5,096 ) (5,535 ) Total debt outstanding, at carrying value $ 4,402,963 $ 4,430,011 Reported as: Current portion of long-term debt, and commercial paper $ 628,614 $ 662,308 Long-term debt 3,774,349 3,767,703 Total debt outstanding, at carrying value $ 4,402,963 $ 4,430,011 ____________________________ (1) As of the report date, these notes were convertible at the option of the bondholder. This is a result of the following condition being met: the market value of the Company’s Common Stock was greater than 130% of the convertible notes conversion price for 20 or more of the 30 consecutive trading days preceding the quarter-end. As a result, the 2041 Notes were classified in current liabilities and a portion of the equity component, associated with the convertible notes representing the unamortized discount, was classified in temporary equity on the Company’s Consolidated Balance Sheets. Upon closure of the conversion period, the notes not converted will be reclassified back into noncurrent liabilities and the temporary equity will be reclassified into permanent equity. (2) This amount includes a cumulative fair market gain of $2.8 million for discontinued hedging relationships, net of an immaterial amount of amortization for the three and six months ended December 29, 2019 .
Components of Convertible Notes	Selected additional information regarding the 2041 Notes outstanding as of December 29, 2019 , and June 30, 2019 , is as follows: December 29, June 30, 2041 Notes 2041 Notes (in thousands, except years, percentages, conversion rate, and conversion price) Carrying amount of permanent equity component, net of tax $ 161,271 $ 160,604 Carrying amount of temporary equity component, net of tax $ 38,304 $ 49,439 Remaining amortization period (years) 21.4 21.9 Fair Value of Notes (Level 2) $ 1,532,188 Conversion rate (shares of common stock per $1,000 principal amount of notes) 31.2089 Conversion price (per share of common stock) $ 32.04 If-converted value in excess of par value $ 1,364,475 Estimated share dilution using average quarterly stock price $264.15 per share 4,582
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments	Selected additional information regarding the Senior Notes outstanding as of December 29, 2019 , is as follows: Remaining Amortization period Fair Value of Notes (Level 2) (years) (in thousands) 2020 Notes 0.2 $ 500,410 2021 Notes 1.5 $ 809,552 2025 Notes 5.2 $ 536,190 2026 Notes 6.2 $ 805,748 2029 Notes 9.2 $ 1,104,060 2049 Notes 29.2 $ 947,325
Schedule of Recognized Interest Cost Relating to Both Contractual Interest Coupon and Amortization of Discount on Liability Component of Notes	The following table presents the amount of interest cost recognized relating to both the contractual interest coupon and amortization of the debt discount, issuance costs, and effective portion of interest rate contracts with respect to the Senior Notes, convertible notes, the term loan agreement, commercial paper, and the revolving credit facility during the three and six months ended December 29, 2019 and December 23, 2018 . Three Months Ended Six Months Ended December 29, December 23, December 29, December 23, (in thousands) Contractual interest coupon $ 40,665 $ 16,550 $ 81,787 $ 33,977 Amortization of interest discount 1,158 887 2,393 1,787 Amortization of issuance costs 416 329 830 658 Effect of interest rate contracts, net 155 777 830 1,530 Total interest cost recognized $ 42,394 $ 18,543 $ 85,840 $ 37,952

LEASES (Tables)

LEASES (Tables)	6 Months Ended
	Dec. 29, 2019
Leases [Abstract]
Components of Lease Expense	The components of lease expense were as follows: Three Months Ended Six Months Ended December 29, December 29, (in thousands) Financing lease cost: Amortization of right-of-use assets $ 891 $ 1,819 Interest on lease liabilities 115 265 Total finance lease cost $ 1,006 $ 2,084 Operating lease cost $ 10,421 $ 21,185 Variable lease cost 22,071 41,018
Supplemental Cash Flow Information	Supplemental cash flow information related to leases was as follows: Six Months Ended December 29, 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows paid for operating leases $ 19,384 Financing cash flows paid for principal portion of finance leases 1,647 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 11,968 Finance leases 1,357 December 29, 2019 Weighted-Average Remaining Lease Term Weighted-Average Discount Rate (in years) Operating leases 4.4 2.57 % Finance leases 4.3 2.82 %
Supplemental Balance Sheet Information	Supplemental balance sheet information related to leases were as follows: December 29, 2019 (in thousands) Operating leases Other assets $ 101,605 Accrued expenses and other current liabilities $ 36,480 Other long-term liabilities 70,442 Total operating lease liabilities $ 106,922 Finance Leases Property and Equipment, net $ 18,684 Current portion of long-term debt and lease liabilities $ 3,677 Long-term debt and lease liabilities 11,719 Total finance lease liabilities $ 15,396 December 29, 2019 Weighted-Average Remaining Lease Term Weighted-Average Discount Rate (in years) Operating leases 4.4 2.57 % Finance leases 4.3 2.82 %
Maturities of Finance Lease Liabilities	As of December 29, 2019 , the maturities of lease liabilities are as follows: Fiscal Year Operating Leases Finance Leases (in thousands) 2020 (remaining 6 months) $ 19,237 $ 2,022 2021 34,265 3,548 2022 18,256 6,208 2023 11,659 1,200 2024 8,591 841 Thereafter 20,809 2,920 Total lease payments $ 112,817 $ 16,739 Less imputed interest (5,895 ) (1,343 ) Total $ 106,922 $ 15,396
Maturities of Operating Lease Liabilities	As of December 29, 2019 , the maturities of lease liabilities are as follows: Fiscal Year Operating Leases Finance Leases (in thousands) 2020 (remaining 6 months) $ 19,237 $ 2,022 2021 34,265 3,548 2022 18,256 6,208 2023 11,659 1,200 2024 8,591 841 Thereafter 20,809 2,920 Total lease payments $ 112,817 $ 16,739 Less imputed interest (5,895 ) (1,343 ) Total $ 106,922 $ 15,396

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	6 Months Ended
	Dec. 29, 2019
Commitments and Contingencies Disclosure [Abstract]
Warranties	Changes in the Company’s product warranty reserves were as follows: Three Months Ended Six Months Ended December 29, December 23, December 29, December 23, (in thousands) Balance at beginning of period $ 114,470 $ 157,363 $ 127,932 $ 169,407 Warranties issued during the period 40,419 36,853 70,899 72,793 Settlements made during the period (31,848 ) (44,199 ) (66,916 ) (89,506 ) Changes in liability for pre-existing warranties (4,848 ) (2,262 ) (13,722 ) (4,939 ) Balance at end of period $ 118,193 $ 147,755 $ 118,193 $ 147,755

STOCK REPURCHASE PROGRAM (Table

STOCK REPURCHASE PROGRAM (Tables)	6 Months Ended
	Dec. 29, 2019
Equity [Abstract]
Repurchases Under the Repurchase Program	Repurchases under the repurchase program were as follows during the periods indicated: Period Total Number of Total Cost of Average Price (1) Amount (in thousands, except per share data) Available balance as of June 30, 2019 $ 3,033,500 Quarter ended September 29, 2019 383 $ 75,196 $ 196.34 $ 2,958,304 Quarter ended December 29, 2019 3,224 $ 1,000,475 $ — $ 1,957,829 (1) Average price paid per share excludes the effect of accelerated share repurchases. See additional disclosure below regarding the Company’s accelerated share repurchase activity during the six months ended December 29, 2019.

ACCUMULATED OTHER COMPREHENSI_2

ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)	6 Months Ended
	Dec. 29, 2019
Equity [Abstract]
Components of Accumulated Other Comprehensive Income (Loss)	The components of accumulated other comprehensive income (loss), net of tax at December 29, 2019 , as well as the activity for the six months ending December 29, 2019 , were as follows: Accumulated Foreign Currency Translation Adjustment Accumulated Accumulated Accumulated Total (in thousands) Balance at June 30, 2019 $ (39,370 ) $ (4,330 ) $ 2,146 $ (22,476 ) $ (64,030 ) Other comprehensive (loss) income before reclassifications (1,174 ) 3,388 (2,713 ) 578 79 (Gains) losses reclassified from accumulated other comprehensive income (loss) to net income (13 ) 2,734 (1) 983 (2) — 3,704 Net current-period other comprehensive (loss) income (1,187 ) 6,122 (1,730 ) 578 3,783 Balance at December 29, 2019 $ (40,557 ) $ 1,792 $ 416 $ (21,898 ) $ (60,247 ) (1) Amount of after tax loss reclassified from AOCI into net income located in revenue: $0.4 million loss; cost of goods sold: $1.6 million loss; and selling, general, and administrative expenses: $0.7 million loss. (2) Amount of after tax loss reclassified from accumulated other comprehensive income into net income located in other expense, net.

RECENT ACCOUNTING PRONOUNCEME_2

RECENT ACCOUNTING PRONOUNCEMENTS - Additional Information (Details) - USD ($) $ in Thousands		Dec. 29, 2019	Jul. 01, 2019	Jun. 30, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating right-of-use assets		$ 101,605
Net lease liability		106,922
Property and equipment, net	[1]			$ (1,059,077)
Current portion of long-term debt and finance lease obligations		$ (632,292)		$ (667,131)	[1]
ASU 2016-02
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating right-of-use assets			$ 110,800
Deferred rent liabilities			3,000
Net lease liability			113,800
Cumulative-effect adjustment to retained earnings			3,018
Property and equipment, net			40,400
Finance leases			43,800
Current portion of long-term debt and finance lease obligations			42,300
ASU 2016-02 | Retained earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative-effect adjustment to retained earnings			$ 3,018
[1]	Derived from audited financial statements

REVENUE - Additional Informatio

REVENUE - Additional Information (Details) $ in Millions	3 Months Ended	6 Months Ended
	Dec. 29, 2019USD ($)	Dec. 29, 2019USD ($)regionsegmentmarket
Revenue from Contract with Customer [Abstract]
Revenue recognized | $	$ 125.9	$ 323.9
Number reportable business segment | segment		1
Number of operating geographic regions | region		7
Number of primary markets | market		3

REVENUE - Summary of Contract T

REVENUE - Summary of Contract Transaction Price not yet Recognized as Revenue (Details) $ in Thousands	Dec. 29, 2019USD ($)
Revenue from Contract with Customer [Abstract]
Deferred revenue	$ 410,761
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2019-12-30
Revenue from Contract with Customer [Abstract]
Deferred revenue	$ 372,927
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue, expected timing of satisfaction	2 years
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-07-01
Revenue from Contract with Customer [Abstract]
Deferred revenue	$ 37,834
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-06-28
Revenue from Contract with Customer [Abstract]
Deferred revenue	$ 0
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-06-26
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue, expected timing of satisfaction

REVENUE - Disaggregation of Rev

REVENUE - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 29, 2019	Dec. 23, 2018	Dec. 29, 2019	Dec. 23, 2018
Disaggregation of Revenue [Line Items]
Revenue	$ 2,583,501	$ 2,522,673	$ 4,749,247	$ 4,853,364
China
Disaggregation of Revenue [Line Items]
Revenue	758,286	361,782	1,349,954	955,613
Taiwan
Disaggregation of Revenue [Line Items]
Revenue	680,871	425,533	1,072,363	705,583
Korea
Disaggregation of Revenue [Line Items]
Revenue	463,178	631,502	914,661	1,011,272
United States
Disaggregation of Revenue [Line Items]
Revenue	223,725	135,696	407,384	255,801
Japan
Disaggregation of Revenue [Line Items]
Revenue	208,240	691,817	481,913	1,361,857
Southeast Asia
Disaggregation of Revenue [Line Items]
Revenue	184,168	165,204	397,923	363,340
Europe
Disaggregation of Revenue [Line Items]
Revenue	$ 65,033	$ 111,139	$ 125,049	$ 199,898

REVENUE - Schedule of System Re

REVENUE - Schedule of System Revenues of Primary Markets (Details) - Systems revenue	3 Months Ended		6 Months Ended
	Dec. 29, 2019	Dec. 23, 2018	Dec. 29, 2019	Dec. 23, 2018
Memory
Concentration Risk [Line Items]
Primary market revenue, percent	52.00%	79.00%	58.00%	78.00%
Foundry
Concentration Risk [Line Items]
Primary market revenue, percent	36.00%	13.00%	31.00%	15.00%
Logic/integrated device manufacturing
Concentration Risk [Line Items]
Primary market revenue, percent	12.00%	8.00%	11.00%	7.00%

EQUITY-BASED COMPENSATION PLA_3

EQUITY-BASED COMPENSATION PLANS - Additional Information (Details)	6 Months Ended
	Dec. 29, 2019
Share-based Payment Arrangement [Abstract]
Vesting period (years)	3 years

EQUITY-BASED COMPENSATION PLA_4

EQUITY-BASED COMPENSATION PLANS - Recognized Equity-Based Compensation Expenses and Related Income Tax Benefit (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 29, 2019	Dec. 23, 2018	Dec. 29, 2019	Dec. 23, 2018
Share-based Payment Arrangement [Abstract]
Equity-based compensation expense	$ 45,725	$ 38,806	$ 88,630	$ 89,149
Income tax benefit recognized related to equity-based compensation expense	$ 4,461	$ 5,763	$ 14,279	$ 13,867

OTHER EXPENSE, NET (Details)

OTHER EXPENSE, NET (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 29, 2019	Dec. 23, 2018	Dec. 29, 2019	Dec. 23, 2018
Other Income and Expenses [Abstract]
Interest income	$ 25,454	$ 17,809	$ 57,238	$ 36,742
Interest expense	(42,615)	(19,784)	(86,610)	(41,572)
Gains (losses) on deferred compensation plan-related assets, net	14,129	(22,374)	13,693	(17,160)
Foreign exchange (losses) gains, net	(2,287)	2,581	(2,816)	2,632
Other, net	(8,605)	(8,881)	(8,157)	(11,668)
Other expense, net	$ (13,924)	$ (30,649)	$ (26,652)	$ (31,026)

INCOME TAX EXPENSE (Details)

INCOME TAX EXPENSE (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 29, 2019	Dec. 23, 2018	Dec. 29, 2019	Dec. 23, 2018
Income Tax Disclosure [Abstract]
Income tax expense	$ 158,077	$ 90,875	$ 217,015	$ 148,889
Effective income tax rate	23.50%		18.10%
Tax Adjustments, Settlements, and Unusual Provisions	$ 74,500
Tax examinations or lapses of statute of limitation
Income Tax Contingency [Line Items]
Estimated unrecognized tax benefits reduction	$ 10,000		$ 10,000

NET INCOME PER SHARE - Schedule

NET INCOME PER SHARE - Schedule of Numerators and Denominators of Basic and Diluted Computations for Net Income Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 29, 2019	Dec. 23, 2018	Dec. 29, 2019	Dec. 23, 2018
Numerator:
Net income	$ 514,510	$ 568,855	$ 980,299	$ 1,102,215
Denominator:
Basic average shares outstanding (shares)	143,987	155,022	144,330	155,340
Effect of potential dilutive securities:
Employee stock plans (shares)	1,528	1,435	1,359	1,487
Convertible notes (shares)	4,582	5,713	4,700	5,894
Warrants (shares)	0	0	0	1,028
Diluted average shares outstanding (shares)	150,097	162,170	150,389	163,749
Net income per share - basic (usd per share)	$ 3.57	$ 3.67	$ 6.79	$ 7.10
Net income per share - diluted (usd per share)	$ 3.43	$ 3.51	$ 6.52	$ 6.73

NET INCOME PER SHARE - Schedu_2

NET INCOME PER SHARE - Schedule of Potentially Dilutive Securities Excluded from EPS Calculations (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Dec. 29, 2019	Dec. 23, 2018	Dec. 29, 2019	Dec. 23, 2018
Options and RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Number of potentially dilutive securities (shares)	3	227	4	890

FINANCIAL INSTRUMENTS - Cash, C

FINANCIAL INSTRUMENTS - Cash, Cash Equivalents, Investments, Restricted Cash and Investments and Other Assets Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands	Dec. 29, 2019	Jun. 30, 2019		Dec. 23, 2018
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt securities, cost	$ 4,356,983
Total cost	5,012,545	$ 5,760,736
Total, unrealized gain	6,694	3,836
Total unrealized (loss)	(994)	(451)
Total fair value	5,018,245	5,764,121
Cash and Cash Equivalents	3,035,887	3,658,219	[1]	$ 3,359,793
Investments	1,647,867	1,772,984	[1]
Restricted cash and investments	253,907	255,177	[1]
Other Assets	80,584	77,741
Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total cost	1,528,924	2,187,275
Total, unrealized gain	5,908	1,346
Total unrealized (loss)	(506)	(307)
Total fair value	1,534,326	2,188,314
Cash and Cash Equivalents	977,274	1,731,640
Investments	476,468	378,933
Restricted cash and investments	0	0
Other Assets	80,584	77,741
Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total cost	1,296,775	1,542,315
Total, unrealized gain	786	2,490
Total unrealized (loss)	(488)	(144)
Total fair value	1,297,073	1,544,661
Cash and Cash Equivalents	125,674	150,610
Investments	1,171,399	1,394,051
Restricted cash and investments	0	0
Other Assets	0	0
Cash
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	580,318	467,460
Cash and Cash Equivalents	576,439	462,310
Investments	0	0
Restricted cash and investments	3,879	5,150
Other Assets	0	0
Time deposit
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	1,606,528	1,563,686
Cash and Cash Equivalents	1,356,500	1,313,659
Investments	0	0
Restricted cash and investments	250,028	250,027
Other Assets	0	0
Money market funds | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt securities, cost	977,274	1,644,659
Debt securities, unrealized gain	0	0
Debt securities, unrealized (loss)	0	0
Debt securities, fair value	977,274	1,644,659
Cash and Cash Equivalents	977,274	1,644,659
Investments	0	0
Restricted cash and investments	0	0
Other Assets	0	0
U.S. Treasury and agencies | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt securities, cost	476,406	465,655
Debt securities, unrealized gain	116	283
Debt securities, unrealized (loss)	(54)	(24)
Debt securities, fair value	476,468	465,914
Cash and Cash Equivalents	0	86,981
Investments	476,468	378,933
Restricted cash and investments	0	0
Other Assets	0	0
Mutual funds | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Trading securities, cost	75,244	76,961
Trading securities, unrealized gain	5,792	1,063
Trading securities, unrealized (loss)	(452)	(283)
Trading securities, fair value	80,584	77,741
Cash and Cash Equivalents	0	0
Investments	0	0
Restricted cash and investments	0	0
Other Assets	80,584	77,741
Government-sponsored enterprises | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt securities, cost	9,819	16,005
Debt securities, unrealized gain	0	5
Debt securities, unrealized (loss)	(3)	(41)
Debt securities, fair value	9,816	15,969
Cash and Cash Equivalents	2,799	0
Investments	7,017	15,969
Restricted cash and investments	0	0
Other Assets	0	0
Foreign government bonds | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt securities, cost	30,507	24,408
Debt securities, unrealized gain	2	35
Debt securities, unrealized (loss)	(6)	0
Debt securities, fair value	30,503	24,443
Cash and Cash Equivalents	0	0
Investments	30,503	24,443
Restricted cash and investments	0	0
Other Assets	0	0
Corporate notes and bonds | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt securities, cost	1,225,526	1,466,167
Debt securities, unrealized gain	742	2,310
Debt securities, unrealized (loss)	(444)	(99)
Debt securities, fair value	1,225,824	1,468,378
Cash and Cash Equivalents	122,875	150,610
Investments	1,102,949	1,317,768
Restricted cash and investments	0	0
Other Assets	0	0
Mortgage backed securities — residential | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt securities, cost	4,172	6,148
Debt securities, unrealized gain	8	0
Debt securities, unrealized (loss)	0	(4)
Debt securities, fair value	4,180	6,144
Cash and Cash Equivalents	0	0
Investments	4,180	6,144
Restricted cash and investments	0	0
Other Assets	0	0
Mortgage backed securities — commercial | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt securities, cost	26,751	29,587
Debt securities, unrealized gain	34	140
Debt securities, unrealized (loss)	(35)	0
Debt securities, fair value	26,750	29,727
Cash and Cash Equivalents	0	0
Investments	26,750	29,727
Restricted cash and investments	0	0
Other Assets	$ 0	$ 0
[1]	Derived from audited financial statements

FINANCIAL INSTRUMENTS - Additio

FINANCIAL INSTRUMENTS - Additional Information (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 29, 2019	Dec. 23, 2018	Dec. 29, 2019	Dec. 23, 2018	Jan. 31, 2020	Jun. 30, 2019
Derivative Instruments, Gain (Loss) [Line Items]
Other than temporary impairment losses, investments	$ 0	$ 0	$ 0	$ 0
Net unrealized gains during the period	4,079,000		3,388,000
Foreign exchange and interest rate contracts
Derivative Instruments, Gain (Loss) [Line Items]
Foreign exchange contracts amount of offset, assets	2,300,000		2,300,000			$ 2,400,000
Foreign exchange contracts amount of offset, liabilities	2,300,000		2,300,000			2,400,000
Net derivative asset from master netting agreements	3,800,000		3,800,000			500,000
Net derivative liability from master netting agreements	700,000		700,000			$ 6,200,000
Cash Flow Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Gain reclassification from AOCI to income, in the next 12 months			2,000,000
Losses accumulated in other comprehensive income expected to reclassify from other comprehensive income into earnings			$ (2,100,000)
Gains (losses) accumulated in other comprehensive income expected to reclassify from other comprehensive income into earnings, estimate of time to transfer			5 years 2 months 12 days
Cash Flow Hedges | Interest rate swap agreement
Derivative Instruments, Gain (Loss) [Line Items]
Derivative notional amount	$ 200,000,000		$ 200,000,000
Net unrealized gains during the period			$ 1,900,000
Minimum | Cash Flow Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Foreign currency cash flow hedge, expiration period			12 months
Maximum | Cash Flow Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Foreign currency cash flow hedge, expiration period			24 months
Subsequent event | Cash Flow Hedges | Interest rate swap agreement
Derivative Instruments, Gain (Loss) [Line Items]
Derivative notional amount					$ 200,000,000

FINANCIAL INSTRUMENTS - Schedul

FINANCIAL INSTRUMENTS - Schedule of Cash, Cash Equivalents, Investments and Restricted Cash and Investments Unrealized Loss Positions (Details) $ in Thousands	Dec. 29, 2019USD ($)
Fair Value
Unrealized Losses Less than 12 Months	$ 1,077,654
Unrealized Losses 12 Months or Greater	21,730
Total	1,099,384
Gross Unrealized Loss
Unrealized Losses Less than 12 Months	(731)
Unrealized Losses 12 Months or Greater	(263)
Total	(994)
U.S. Treasury and agencies
Fair Value
Unrealized losses less than 12 months, available for sale	325,502
Unrealized losses 12 months or greater, available for sale	0
Total, available for sale	325,502
Gross Unrealized Loss
Unrealized losses less than 12 months, available for sale	(54)
Unrealized losses 12 months or greater, available for sale	0
Total, available for sale	(54)
Mutual funds
Fair Value
Unrealized losses less than 12 months, trading	2,925
Unrealized losses 12 months or greater, trading	7,955
Total, trading	10,880
Gross Unrealized Loss
Unrealized losses less than 12 months, trading	(195)
Unrealized losses 12 months or greater, trading	(257)
Total, trading	(452)
Government-sponsored enterprises
Fair Value
Unrealized losses less than 12 months, available for sale	0
Unrealized losses 12 months or greater, available for sale	6,995
Total, available for sale	6,995
Gross Unrealized Loss
Unrealized losses less than 12 months, available for sale	0
Unrealized losses 12 months or greater, available for sale	(3)
Total, available for sale	(3)
Foreign government bonds
Fair Value
Unrealized losses less than 12 months, available for sale	29,420
Unrealized losses 12 months or greater, available for sale	0
Total, available for sale	29,420
Gross Unrealized Loss
Unrealized losses less than 12 months, available for sale	(6)
Unrealized losses 12 months or greater, available for sale	0
Total, available for sale	(6)
Corporate notes and bonds
Fair Value
Unrealized losses less than 12 months, available for sale	703,002
Unrealized losses 12 months or greater, available for sale	6,780
Total, available for sale	709,782
Gross Unrealized Loss
Unrealized losses less than 12 months, available for sale	(441)
Unrealized losses 12 months or greater, available for sale	(3)
Total, available for sale	(444)
Mortgage backed securities — commercial
Fair Value
Unrealized losses less than 12 months, available for sale	16,805
Unrealized losses 12 months or greater, available for sale	0
Total, available for sale	16,805
Gross Unrealized Loss
Unrealized losses less than 12 months, available for sale	(35)
Unrealized losses 12 months or greater, available for sale	0
Total, available for sale	$ (35)

FINANCIAL INSTRUMENTS - Sched_2

FINANCIAL INSTRUMENTS - Schedule of Amortized Cost and Fair Value of Cash Equivalents, Investments, and Restricted Cash and Investments with Contractual Maturities (Details) $ in Thousands	Dec. 29, 2019USD ($)
Cost
Due in one year or less	$ 3,889,431
Due after one year through five years	444,558
Due in more than five years	22,994
Debt securities, cost	4,356,983
Estimated Fair Value
Due in one year or less	3,889,377
Due after one year through five years	444,950
Due in more than five years	23,016
Total	$ 4,357,343

FINANCIAL INSTRUMENTS - Sched_3

FINANCIAL INSTRUMENTS - Schedule of Outstanding Foreign Currency Forward Contracts (Details) - Foreign exchange contracts - Foreign currency forward contracts $ in Thousands	Dec. 29, 2019USD ($)
Buy Contracts | Derivatives designated as hedging instruments
Derivative [Line Items]
Derivative notional amount	$ 76,408
Buy Contracts | Derivatives designated as hedging instruments | Japanese yen
Derivative [Line Items]
Derivative notional amount	0
Buy Contracts | Derivatives designated as hedging instruments | Euro
Derivative [Line Items]
Derivative notional amount	61,007
Buy Contracts | Derivatives designated as hedging instruments | Korean won
Derivative [Line Items]
Derivative notional amount	15,401
Buy Contracts | Derivatives designated as hedging instruments | British pound sterling
Derivative [Line Items]
Derivative notional amount	0
Buy Contracts | Derivatives designated as hedging instruments | Taiwan dollar
Derivative [Line Items]
Derivative notional amount	0
Buy Contracts | Derivatives designated as hedging instruments | Chinese renminbi
Derivative [Line Items]
Derivative notional amount	0
Buy Contracts | Derivatives designated as hedging instruments | Swiss franc
Derivative [Line Items]
Derivative notional amount	0
Buy Contracts | Derivatives designated as hedging instruments | Singapore dollar
Derivative [Line Items]
Derivative notional amount	0
Buy Contracts | Derivatives designated as hedging instruments | Indian rupee
Derivative [Line Items]
Derivative notional amount	0
Buy Contracts | Derivatives not designated as hedging instruments
Derivative [Line Items]
Derivative notional amount	268,879
Buy Contracts | Derivatives not designated as hedging instruments | Japanese yen
Derivative [Line Items]
Derivative notional amount	61,301
Buy Contracts | Derivatives not designated as hedging instruments | Euro
Derivative [Line Items]
Derivative notional amount	42,371
Buy Contracts | Derivatives not designated as hedging instruments | Korean won
Derivative [Line Items]
Derivative notional amount	0
Buy Contracts | Derivatives not designated as hedging instruments | British pound sterling
Derivative [Line Items]
Derivative notional amount	48,439
Buy Contracts | Derivatives not designated as hedging instruments | Taiwan dollar
Derivative [Line Items]
Derivative notional amount	33,328
Buy Contracts | Derivatives not designated as hedging instruments | Chinese renminbi
Derivative [Line Items]
Derivative notional amount	31,683
Buy Contracts | Derivatives not designated as hedging instruments | Swiss franc
Derivative [Line Items]
Derivative notional amount	22,493
Buy Contracts | Derivatives not designated as hedging instruments | Singapore dollar
Derivative [Line Items]
Derivative notional amount	21,409
Buy Contracts | Derivatives not designated as hedging instruments | Indian rupee
Derivative [Line Items]
Derivative notional amount	7,855
Sell Contracts | Derivatives designated as hedging instruments
Derivative [Line Items]
Derivative notional amount	100,830
Sell Contracts | Derivatives designated as hedging instruments | Japanese yen
Derivative [Line Items]
Derivative notional amount	100,830
Sell Contracts | Derivatives designated as hedging instruments | Euro
Derivative [Line Items]
Derivative notional amount	0
Sell Contracts | Derivatives designated as hedging instruments | Korean won
Derivative [Line Items]
Derivative notional amount	0
Sell Contracts | Derivatives designated as hedging instruments | British pound sterling
Derivative [Line Items]
Derivative notional amount	0
Sell Contracts | Derivatives designated as hedging instruments | Taiwan dollar
Derivative [Line Items]
Derivative notional amount	0
Sell Contracts | Derivatives designated as hedging instruments | Chinese renminbi
Derivative [Line Items]
Derivative notional amount	0
Sell Contracts | Derivatives designated as hedging instruments | Swiss franc
Derivative [Line Items]
Derivative notional amount	0
Sell Contracts | Derivatives designated as hedging instruments | Singapore dollar
Derivative [Line Items]
Derivative notional amount	0
Sell Contracts | Derivatives designated as hedging instruments | Indian rupee
Derivative [Line Items]
Derivative notional amount	0
Sell Contracts | Derivatives not designated as hedging instruments
Derivative [Line Items]
Derivative notional amount	4,294
Sell Contracts | Derivatives not designated as hedging instruments | Japanese yen
Derivative [Line Items]
Derivative notional amount	0
Sell Contracts | Derivatives not designated as hedging instruments | Euro
Derivative [Line Items]
Derivative notional amount	0
Sell Contracts | Derivatives not designated as hedging instruments | Korean won
Derivative [Line Items]
Derivative notional amount	4,294
Sell Contracts | Derivatives not designated as hedging instruments | British pound sterling
Derivative [Line Items]
Derivative notional amount	0
Sell Contracts | Derivatives not designated as hedging instruments | Taiwan dollar
Derivative [Line Items]
Derivative notional amount	0
Sell Contracts | Derivatives not designated as hedging instruments | Chinese renminbi
Derivative [Line Items]
Derivative notional amount	0
Sell Contracts | Derivatives not designated as hedging instruments | Swiss franc
Derivative [Line Items]
Derivative notional amount	0
Sell Contracts | Derivatives not designated as hedging instruments | Singapore dollar
Derivative [Line Items]
Derivative notional amount	0
Sell Contracts | Derivatives not designated as hedging instruments | Indian rupee
Derivative [Line Items]
Derivative notional amount	$ 0

FINANCIAL INSTRUMENTS - Sched_4

FINANCIAL INSTRUMENTS - Schedule of Fair Value of Derivative Instruments (Details) - Fair Value of Derivative Instruments (Level 2) - USD ($) $ in Thousands	Dec. 29, 2019	Jun. 30, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets	$ 6,063	$ 2,905
Derivative Liabilities	2,962	8,653
Derivatives designated as hedging instruments | Prepaid expense and other assets | Foreign exchange contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets	2,437	119
Derivatives designated as hedging instruments | Accrued expenses and other current liabilities | Foreign exchange contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities	16	2,756
Derivatives designated as hedging instruments | Accrued expenses and other current liabilities | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities	2,746	5,149
Derivatives designated as hedging instruments | Other assets | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets	3,605	1,537
Derivatives not designated as hedging instruments | Prepaid expense and other assets | Foreign exchange contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets	21	1,249
Derivatives not designated as hedging instruments | Accrued expenses and other current liabilities | Foreign exchange contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities	$ 200	$ 748

FINANCIAL INSTRUMENTS - Sched_5

FINANCIAL INSTRUMENTS - Schedule of Derivative Instruments Designated as Cash Flow Hedges in Statements of Operations Including Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 29, 2019	Dec. 23, 2018	Dec. 29, 2019	Dec. 23, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Revenue	$ 2,583,501	$ 2,522,673	$ 4,749,247	$ 4,853,364
Cost of goods sold	1,403,857	1,377,640	2,587,893	2,650,133
Selling, general, and administrative	174,272	169,098	331,700	343,873
Other expense, net	(13,924)	(30,649)	(26,652)	(31,026)
Foreign Exchange Contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) Recognized in AOCI	4,984	5,590	4,060	13,703
Foreign Exchange Contracts | Revenue
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) Recognized in AOCI	2,264	8,229	3,198	16,670
Foreign Exchange Contracts | Revenue | Cash flow hedging
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain or (loss) on cash flow hedging relationships in Subtopic 815-20	(172)		(506)
Foreign Exchange Contracts | Cost of goods sold
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) Recognized in AOCI	196	(1,965)	(1,067)	(2,089)
Foreign Exchange Contracts | Cost of goods sold | Cash flow hedging
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain or (loss) on cash flow hedging relationships in Subtopic 815-20	(1,090)		(1,900)
Foreign Exchange Contracts | Selling, general, and administrative
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) Recognized in AOCI	130	(674)	(465)	(878)
Foreign Exchange Contracts | Selling, general, and administrative | Cash flow hedging
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain or (loss) on cash flow hedging relationships in Subtopic 815-20	(417)		(893)
Foreign Exchange Contracts | Other expense, net | Cash flow hedging
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain or (loss) on cash flow hedging relationships in Subtopic 815-20	0		0
Foreign Exchange Contracts | Other income
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) derivative instruments not designated as cash flow hedges	3,571	301	(1,930)	10,889
Foreign Exchange Contracts | Reclassified from accumulated other comprehensive income
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) Reclassified from AOCI into Income	(1,714)	6,278	(3,369)	4,835
Foreign Exchange Contracts | Reclassified from accumulated other comprehensive income | Revenue
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) Reclassified from AOCI into Income	(172)	7,813	(506)	8,487
Foreign Exchange Contracts | Reclassified from accumulated other comprehensive income | Cost of goods sold
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) Reclassified from AOCI into Income	(1,090)	(851)	(1,900)	(2,408)
Foreign Exchange Contracts | Reclassified from accumulated other comprehensive income | Selling, general, and administrative
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) Reclassified from AOCI into Income	(417)	(651)	(893)	(1,178)
Interest Rate Contracts | Revenue | Fair value hedging
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain or (loss) on fair value hedging relationships in Subtopic 815-20	0		0
Interest Rate Contracts | Revenue | Fair value hedging | Derivatives designated as hedging instruments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain or (loss) on fair value hedging relationships in Subtopic 815-20	0		0
Interest Rate Contracts | Revenue | Cash flow hedging
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain or (loss) on cash flow hedging relationships in Subtopic 815-20	0		0
Interest Rate Contracts | Cost of goods sold | Fair value hedging
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain or (loss) on fair value hedging relationships in Subtopic 815-20	0		0
Interest Rate Contracts | Cost of goods sold | Fair value hedging | Derivatives designated as hedging instruments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain or (loss) on fair value hedging relationships in Subtopic 815-20	0		0
Interest Rate Contracts | Cost of goods sold | Cash flow hedging
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain or (loss) on cash flow hedging relationships in Subtopic 815-20	0		0
Interest Rate Contracts | Selling, general, and administrative | Fair value hedging
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain or (loss) on fair value hedging relationships in Subtopic 815-20	0		0
Interest Rate Contracts | Selling, general, and administrative | Fair value hedging | Derivatives designated as hedging instruments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain or (loss) on fair value hedging relationships in Subtopic 815-20	0		0
Interest Rate Contracts | Selling, general, and administrative | Cash flow hedging
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain or (loss) on cash flow hedging relationships in Subtopic 815-20	0		0
Interest Rate Contracts | Other expense, net
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) Recognized in AOCI	2,394	0	2,394	0
Interest Rate Contracts | Other expense, net | Fair value hedging
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain or (loss) on fair value hedging relationships in Subtopic 815-20	2,342		(5,092)
Interest Rate Contracts | Other expense, net | Fair value hedging | Derivatives designated as hedging instruments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain or (loss) on fair value hedging relationships in Subtopic 815-20	(2,342)		5,092
Interest Rate Contracts | Other expense, net | Cash flow hedging
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain or (loss) on cash flow hedging relationships in Subtopic 815-20	(35)		(70)
Interest Rate Contracts | Reclassified from accumulated other comprehensive income | Other expense, net
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) Reclassified from AOCI into Income	$ (35)	$ (33)	$ (70)	$ (66)

INVENTORIES (Details)

INVENTORIES (Details) - USD ($) $ in Thousands	Dec. 29, 2019	Jun. 30, 2019
Inventory Disclosure [Abstract]
Raw materials	$ 980,751	$ 994,738
Work-in-process	200,626	174,219
Finished goods	347,243	371,183
Total inventories	$ 1,528,620	$ 1,540,140	[1]
[1]	Derived from audited financial statements

GOODWILL AND INTANGIBLE ASSET_2

GOODWILL AND INTANGIBLE ASSETS - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 29, 2019	Dec. 23, 2018	Dec. 29, 2019	Dec. 23, 2018	Jun. 30, 2019	[1]
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 1,484,824		$ 1,484,824		$ 1,484,597
Tax deductible goodwill	61,100		61,100
Intangible asset amortization expense	16,500	$ 36,300	32,700	$ 72,700
Capitalized costs for internal-use software	$ 13,500		$ 13,500
[1]	Derived from audited financial statements

GOODWILL AND INTANGIBLE ASSET_3

GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	Dec. 29, 2019	Jun. 30, 2019
Finite-Lived Intangible Assets [Line Items]
Gross	$ 1,434,742	$ 1,425,799
Accumulated Amortization	(1,241,626)	(1,208,849)
Net	193,116	216,950	[1]
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross	630,206	630,165
Accumulated Amortization	(508,199)	(483,204)
Net	122,007	146,961
Existing technology
Finite-Lived Intangible Assets [Line Items]
Gross	669,488	669,399
Accumulated Amortization	(651,379)	(647,837)
Net	18,109	21,562
Patents and other intangible assets
Finite-Lived Intangible Assets [Line Items]
Gross	135,048	126,235
Accumulated Amortization	(82,048)	(77,808)
Net	$ 53,000	$ 48,427
[1]	Derived from audited financial statements

GOODWILL AND INTANGIBLE ASSET_4

GOODWILL AND INTANGIBLE ASSETS - Estimated Future Amortization Expense of Intangible Assets (Details) $ in Thousands	Dec. 29, 2019USD ($)
Fiscal Year
2020 (remaining 6 months)	$ 32,742
2021	63,431
2022	59,093
2023	14,025
2024	7,324
Thereafter	2,962
Net	$ 179,577

ACCRUED EXPENSES AND OTHER CU_3

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) - USD ($) $ in Thousands	Dec. 29, 2019	Jun. 30, 2019
Payables and Accruals [Abstract]
Accrued compensation	$ 390,033	$ 336,090
Warranty reserves	118,193	127,932
Income and other taxes payable	134,615	49,926
Dividend payable	163,510	158,868
Other	307,662	273,825
Accrued expenses and other current liabilities	$ 1,114,013	$ 946,641	[1]
[1]	Derived from audited financial statements

LONG-TERM DEBT AND OTHER BORR_3

LONG-TERM DEBT AND OTHER BORROWINGS - Schedule of Outstanding Debt (Details) $ in Thousands	6 Months Ended
	Dec. 29, 2019USD ($)d	Jun. 30, 2019USD ($)	Mar. 04, 2019	Jun. 07, 2016	Mar. 12, 2015	Jun. 30, 2012
Debt Instrument [Line Items]
Total debt outstanding, at par	$ 4,467,091	$ 4,512,349
Unamortized discount	(60,332)	(73,191)
Fair value adjustment - interest rate contracts	1,300	(3,612)
Unamortized bond issuance costs	(5,096)	(5,535)
Total debt outstanding, at carrying value	4,402,963	4,430,011
Current portion of long-term debt, and commercial paper	628,614	662,308
Long-term debt	3,774,349	3,767,703
Cumulative amount of fair value hedging adjustment for discontinued hedging relationships	$ 2,800
Fixed-rate 2.625% Convertible Notes Due May 15, 2041 (2041 Notes)
Debt Instrument [Line Items]
Senior notes interest rate						2.625%
Senior notes | Fixed-rate 2.75% Senior Notes Due March 15, 2020 (2020 Notes)
Debt Instrument [Line Items]
Senior notes interest rate	2.75%				2.75%
Amount	$ 500,000	$ 500,000
Effective Interest Rate	2.88%	2.88%
Senior notes | Fixed-rate 2.80% Senior Notes Due June 15, 2021 (2021 Notes)
Debt Instrument [Line Items]
Senior notes interest rate	2.80%			2.80%
Amount	$ 800,000	$ 800,000
Effective Interest Rate	2.95%	2.95%
Senior notes | Fixed-rate 3.80% Senior Notes Due March 15, 2025 (2025 Notes)
Debt Instrument [Line Items]
Senior notes interest rate	3.80%				3.80%
Amount	$ 500,000	$ 500,000
Effective Interest Rate	3.87%	3.87%
Senior notes | Fixed-rate 3.75% Senior Notes Due March 15, 2026 (2026 Notes)
Debt Instrument [Line Items]
Senior notes interest rate	3.75%		3.75%
Amount	$ 750,000	$ 750,000
Effective Interest Rate	3.86%	3.86%
Senior notes | Fixed-rate 4.00% Senior Notes Due March 15, 2029 (2029 Notes)
Debt Instrument [Line Items]
Senior notes interest rate	4.00%		4.00%
Amount	$ 1,000,000	$ 1,000,000
Effective Interest Rate	4.09%	4.09%
Senior notes | Fixed-rate 4.875% Senior Notes Due March 15, 2049 (2049 Notes)
Debt Instrument [Line Items]
Senior notes interest rate	4.875%		4.875%
Amount	$ 750,000	$ 750,000
Effective Interest Rate	4.93%	4.93%
Convertible debt | Fixed-rate 2.625% Convertible Notes Due May 15, 2041 (2041 Notes)
Debt Instrument [Line Items]
Senior notes interest rate	2.625%
Amount	$ 167,091	$ 212,349
Effective Interest Rate	4.28%	4.28%
Stock price percentage of conversion price	130.00%
Number of days on which common stock sale price was greater than or equal to 130% of conversion price, in a period of 30 consecutive trading days ending on the last trading day of the preceding the quarter | d	20
Number of consecutive trading days period required | d	30

LONG-TERM DEBT AND OTHER BORR_4

LONG-TERM DEBT AND OTHER BORROWINGS - Convertible Senior Notes (Details) - Fixed-rate 2.625% Convertible Notes Due May 15, 2041 (2041 Notes)	1 Months Ended	3 Months Ended		6 Months Ended
	Jun. 30, 2012USD ($)	Mar. 29, 2020USD ($)	Dec. 29, 2019USD ($)	Dec. 29, 2019USD ($)d
Debt Instrument [Line Items]
Principal amount | $	$ 700,000,000
Senior notes interest rate	2.625%
Convertible debt
Debt Instrument [Line Items]
Senior notes interest rate			2.625%	2.625%
Stock price percentage of conversion price				130.00%
Number of days on which common stock sale price was greater than or equal to 130% of conversion price, in a period of 30 consecutive trading days ending on the last trading day of the preceding the quarter				20
Number of consecutive trading days period required				30
Conversion of notes | $			$ 17,200,000	$ 45,300,000
Convertible debt | Subsequent event | Conversion of 2041 notes
Debt Instrument [Line Items]
Conversion of notes | $		$ 116,600,000
Convertible debt | Redeemable
Debt Instrument [Line Items]
Stock price percentage of conversion price				150.00%
Number of days on which common stock sale price was greater than or equal to 130% of conversion price, in a period of 30 consecutive trading days ending on the last trading day of the preceding the quarter				20
Number of consecutive trading days period required				30
Maximum
Debt Instrument [Line Items]
Maximum amount of contingent interest rate	0.60%

LONG-TERM DEBT AND OTHER BORR_5

LONG-TERM DEBT AND OTHER BORROWINGS - Components of Convertible Senior Notes (Details) - 2041 Notes $ / shares in Units, shares in Thousands	6 Months Ended	12 Months Ended
	Dec. 29, 2019USD ($)$ / sharesshares	Jun. 30, 2019USD ($)
Debt Instrument [Line Items]
Remaining amortization period (years)	21 years 4 months 24 days	21 years 10 months 24 days
Fair Value of Notes (Level 2)	$ 1,532,188,000
Conversion rate (shares of common stock per $1,000 principal amount of notes)	0.0312089
Conversion rate (shares of common stock per $1,000 principal amount of notes)	$ 1,000
Conversion price (per share of common stock) (in usd per share) | $ / shares	$ 32.04
If-converted value in excess of par value	$ 1,364,475,000
Estimated share dilution using average quarterly stock price $264.15 per share | shares	4,582
Share price (usd per share) | $ / shares	$ 264.15
Permanent Equity
Debt Instrument [Line Items]
Carrying amount of equity component, net of tax	$ 161,271,000	$ 160,604,000
Temporary Equity
Debt Instrument [Line Items]
Carrying amount of equity component, net of tax	$ 38,304,000	$ 49,439,000

LONG-TERM DEBT AND OTHER BORR_6

LONG-TERM DEBT AND OTHER BORROWINGS - Senior Notes (Details) - Senior notes - USD ($)	Mar. 12, 2015	Dec. 29, 2019	Mar. 04, 2019	Jun. 07, 2016
Debt Instrument [Line Items]
Debt instrument, redemption price percent	100.00%
2026 Notes
Debt Instrument [Line Items]
Principal amount			$ 750,000,000
Senior notes interest rate		3.75%	3.75%
2029 Notes
Debt Instrument [Line Items]
Principal amount			$ 1,000,000,000
Senior notes interest rate		4.00%	4.00%
2049 Notes
Debt Instrument [Line Items]
Principal amount			$ 750,000,000
Senior notes interest rate		4.875%	4.875%
2020 Notes
Debt Instrument [Line Items]
Principal amount	$ 500,000,000
Senior notes interest rate	2.75%	2.75%
2025 Notes
Debt Instrument [Line Items]
Principal amount	$ 500,000,000
Senior notes interest rate	3.80%	3.80%
2021 Notes
Debt Instrument [Line Items]
Principal amount				$ 800,000,000
Senior notes interest rate		2.80%		2.80%
Debt instrument, redemption price upon occurrence of certain events, percent		101.00%

LONG-TERM DEBT AND OTHER BORR_7

LONG-TERM DEBT AND OTHER BORROWINGS - Schedule of Additional Senior Notes Information (Details) $ in Thousands	6 Months Ended
	Dec. 29, 2019USD ($)
2020 Notes
Debt Instrument [Line Items]
Remaining amortization period (years)	2 months 12 days
2020 Notes | Level 2
Debt Instrument [Line Items]
Fair Value of Notes (Level 2)	$ 500,410
2021 Notes
Debt Instrument [Line Items]
Remaining amortization period (years)	1 year 6 months
2021 Notes | Level 2
Debt Instrument [Line Items]
Fair Value of Notes (Level 2)	$ 809,552
2025 Notes
Debt Instrument [Line Items]
Remaining amortization period (years)	5 years 2 months 12 days
2025 Notes | Level 2
Debt Instrument [Line Items]
Fair Value of Notes (Level 2)	$ 536,190
2026 Notes
Debt Instrument [Line Items]
Remaining amortization period (years)	6 years 2 months 12 days
2026 Notes | Level 2
Debt Instrument [Line Items]
Fair Value of Notes (Level 2)	$ 805,748
2029 Notes
Debt Instrument [Line Items]
Remaining amortization period (years)	9 years 2 months 12 days
2029 Notes | Level 2
Debt Instrument [Line Items]
Fair Value of Notes (Level 2)	$ 1,104,060
2049 Notes
Debt Instrument [Line Items]
Remaining amortization period (years)	29 years 2 months 12 days
2049 Notes | Level 2
Debt Instrument [Line Items]
Fair Value of Notes (Level 2)	$ 947,325

LONG-TERM DEBT AND OTHER BORR_8

LONG-TERM DEBT AND OTHER BORROWINGS - Commercial Paper Program (Details) - Commercial paper - USD ($)	Dec. 29, 2019	Jun. 30, 2019	Nov. 13, 2017
Line of Credit Facility [Line Items]
Unsecured private placement commercial paper notes, maximum aggregate principal			$ 1,250,000,000
Borrowings outstanding	$ 0	$ 0

LONG-TERM DEBT AND OTHER BORR_9

LONG-TERM DEBT AND OTHER BORROWINGS - Revolving Credit Facility (Details) - Revolving credit facility - USD ($)	Feb. 25, 2019	Dec. 29, 2019
Extinguishment of Debt [Line Items]
Revolving unsecured credit facility	$ 1,250,000,000
Additional increase in the facility, available expansion	600,000,000
Revolving unsecured credit facility, available expansion	$ 1,850,000,000
Borrowings outstanding		$ 0
Federal Funds Rate
Extinguishment of Debt [Line Items]
Variable interest spread	0.50%
One-month LIBOR
Extinguishment of Debt [Line Items]
Variable interest spread	1.00%
One-month LIBOR | Minimum
Extinguishment of Debt [Line Items]
Variable interest spread	0.00%
One-month LIBOR | Maximum
Extinguishment of Debt [Line Items]
Variable interest spread	0.50%
LIBOR | Minimum
Extinguishment of Debt [Line Items]
Variable interest spread	0.90%
LIBOR | Maximum
Extinguishment of Debt [Line Items]
Variable interest spread	1.50%

LONG-TERM DEBT AND OTHER BOR_10

LONG-TERM DEBT AND OTHER BORROWINGS - Schedule of Recognized Interest Cost Relating to Both Contractual Interest Coupon and Amortization of Discount on Liability Component of Notes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 29, 2019	Dec. 23, 2018	Dec. 29, 2019	Dec. 23, 2018
Debt Disclosure [Abstract]
Contractual interest coupon	$ 40,665	$ 16,550	$ 81,787	$ 33,977
Amortization of interest discount	1,158	887	2,393	1,787
Amortization of issuance costs	416	329	830	658
Effect of interest rate contracts, net	155	777	830	1,530
Total interest cost recognized	$ 42,394	$ 18,543	$ 85,840	$ 37,952

LEASES - Schedule of Other Oper

LEASES - Schedule of Other Operating Cost and Expense, by Component (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Dec. 29, 2019	Dec. 29, 2019
Financing lease cost:
Amortization of right-of-use assets	$ 891	$ 1,819
Interest on lease liabilities	115	265
Total finance lease cost	1,006	2,084
Operating lease cost	10,421	21,185
Variable lease cost	$ 22,071	$ 41,018

LEASES - Supplemental Cash Flow

LEASES - Supplemental Cash Flows (Details) $ in Thousands	6 Months Ended
	Dec. 29, 2019USD ($)
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows paid for operating leases	$ 19,384
Financing cash flows paid for principal portion of finance leases	1,647
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	11,968
Finance leases	$ 1,357

LEASES - Supplemental Balance S

LEASES - Supplemental Balance Sheet (Details) $ in Thousands	Dec. 29, 2019USD ($)
Operating leases
Other assets	$ 101,605
Accrued expenses and other current liabilities	36,480
Other long-term liabilities	70,442
Total operating lease liabilities	106,922
Finance Leases
Property and Equipment, net	18,684
Current portion of long-term debt and lease liabilities	3,677
Long-term debt and lease liabilities	11,719
Total finance lease liabilities	$ 15,396

LEASES - Weighted-Average Remai

LEASES - Weighted-Average Remaining Lease Term and Discount Rate (Details)	Dec. 29, 2019
Leases [Abstract]
Weighted-Average Remaining Lease Term, Operating leases	4 years 4 months 24 days
Weighted-Average Discount Rate, Operating leases	2.57%
Weighted-Average Remaining Lease Term, Finance leases	4 years 3 months 18 days
Weighted-Average Discount Rate, Finance leases	2.82%

LEASES - Operating Lease Liabil

LEASES - Operating Lease Liability (Details) $ in Thousands	Dec. 29, 2019USD ($)
Operating Leases
2020 (remaining 6 months)	$ 19,237
2021	34,265
2022	18,256
2023	11,659
2024	8,591
Thereafter	20,809
Total lease payments	112,817
Total lease payments	(5,895)
Total	106,922
Finance Leases
2020 (remaining 6 months)	2,022
2021	3,548
2022	6,208
2023	1,200
2024	841
Thereafter	2,920
Total lease payments	16,739
Less imputed interest	(1,343)
Total	$ 15,396

LEASES - Narrative (Details)

LEASES - Narrative (Details) - USD ($)	6 Months Ended
	Dec. 29, 2019	Jun. 30, 2019	[1]
Guarantor Obligations [Line Items]
Restricted cash and investments	$ 253,907,000	$ 255,177,000
Operating Lease Cash Collateral
Guarantor Obligations [Line Items]
Restricted cash and investments	250,000,000
California Operating Leases
Guarantor Obligations [Line Items]
Residual value of operating lease, maximum	$ 220,400,000
Maximum percentage of aggregate investment value guaranteed	100.00%
Guarantee obligation maximum exposure	$ 250,000,000
[1]	Derived from audited financial statements

COMMITMENTS AND CONTINGENCIES -

COMMITMENTS AND CONTINGENCIES - Additional Information (Details) $ in Millions	Dec. 29, 2019USD ($)
Letters of Credit
Loss Contingencies [Line Items]
Guarantee obligation maximum exposure	$ 58.4

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES - Schedule of Changes in Product Warranty Reserves (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 29, 2019	Dec. 23, 2018	Dec. 29, 2019	Dec. 23, 2018
Changes in Product Warranty Reserve
Balance at beginning of period	$ 114,470	$ 157,363	$ 127,932	$ 169,407
Warranties issued during the period	40,419	36,853	70,899	72,793
Settlements made during the period	(31,848)	(44,199)	(66,916)	(89,506)
Changes in liability for pre-existing warranties	(4,848)	(2,262)	(13,722)	(4,939)
Balance at end of period	$ 118,193	$ 147,755	$ 118,193	$ 147,755

STOCK REPURCHASE PROGRAM - Addi

STOCK REPURCHASE PROGRAM - Additional Information (Details) $ / shares in Units, shares in Thousands	Nov. 22, 2019USD ($)financial_institutionagreementshares	Jun. 04, 2019USD ($)financial_institutionagreementshares	Nov. 30, 2019$ / sharesshares	Nov. 30, 2018USD ($)	Dec. 29, 2019USD ($)$ / sharesshares	Sep. 29, 2019$ / sharesshares	Dec. 29, 2019USD ($)shares	Dec. 29, 2019shares
Equity, Class of Treasury Stock [Line Items]
Net shares of settlements to cover tax withholding obligations (shares)					18		32
Amount paid for shares under net share settlements | $					$ 4,900,000		$ 7,800,000
Stock repurchase program
Equity, Class of Treasury Stock [Line Items]
Board authorized increase | $				$ 5,000,000,000
Number of shares repurchased (shares)					3,224	383		3,000,000
Average price paid per share (usd per share) | $ / shares					$ 0	$ 196.34
Stock repurchase program, open Market trading
Equity, Class of Treasury Stock [Line Items]
Number of shares repurchased (shares)							500,000
Stock repurchase program, accelerated share repurchase agreements
Equity, Class of Treasury Stock [Line Items]
Number of shares repurchased (shares)							2,500,000
November 2019 ASR
Equity, Class of Treasury Stock [Line Items]
Number of shares repurchased (shares)	2,900
Number of accelerated share repurchase agreements | agreement	2
Number of financial institutions | financial_institution	2
Accelerated Share Repurchases, Authorized Amount | $	$ 1,000,000,000
Percent of prepayment divided by closing stock price	75.00%
June 2019 ASR
Equity, Class of Treasury Stock [Line Items]
Number of shares repurchased (shares)		3,100	361
Number of accelerated share repurchase agreements | agreement		4
Number of financial institutions | financial_institution		2
Accelerated Share Repurchases, Authorized Amount | $		$ 750,000,000
Percent of prepayment divided by closing stock price		75.00%
Average price paid per share (usd per share) | $ / shares			$ 215.60

STOCK REPURCHASE PROGRAM - Repu

STOCK REPURCHASE PROGRAM - Repurchases Under the Repurchase Program (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended			6 Months Ended		14 Months Ended
	Dec. 29, 2019	Sep. 29, 2019	Dec. 23, 2018	Dec. 29, 2019	Dec. 23, 2018	Dec. 29, 2019	Jun. 30, 2019
Equity, Class of Treasury Stock [Line Items]
Total Cost of Repurchase	$ 1,005,343		$ 1,361	$ 1,083,459	$ 1,737,302
Stock repurchase program
Equity, Class of Treasury Stock [Line Items]
Total Number of Shares Repurchased	3,224	383				3,000,000
Total Cost of Repurchase	$ 1,000,475	$ 75,196
Average Price Paid Per Share (usd per share)	$ 0	$ 196.34
Amount Available Under Repurchase Program	$ 1,957,829	$ 2,958,304		$ 1,957,829		$ 1,957,829	$ 3,033,500

ACCUMULATED OTHER COMPREHENSI_3

ACCUMULATED OTHER COMPREHENSIVE LOSS - Components of Accumulated Other Comprehensive Loss (Details) $ in Thousands	6 Months Ended
	Dec. 29, 2019USD ($)
Change in Accumulated Other Comprehensive Loss
Beginning balance	$ 4,673,865	[1]
Other comprehensive (loss) income before reclassifications	79
(Gains) losses reclassified from accumulated other comprehensive income (loss) to net income	3,704
Other comprehensive income (loss), net of tax	3,783
Ending balance	4,379,429
Accumulated Foreign Currency Translation Adjustment
Change in Accumulated Other Comprehensive Loss
Beginning balance	(39,370)
Other comprehensive (loss) income before reclassifications	(1,174)
(Gains) losses reclassified from accumulated other comprehensive income (loss) to net income	(13)
Other comprehensive income (loss), net of tax	(1,187)
Ending balance	(40,557)
Accumulated Unrealized Gain or Loss on Cash flow hedges
Change in Accumulated Other Comprehensive Loss
Beginning balance	(4,330)
Other comprehensive (loss) income before reclassifications	3,388
(Gains) losses reclassified from accumulated other comprehensive income (loss) to net income	2,734
Other comprehensive income (loss), net of tax	6,122
Ending balance	1,792
Accumulated Unrealized Holding Gain or Loss on Available-For-Sale Investments
Change in Accumulated Other Comprehensive Loss
Beginning balance	2,146
Other comprehensive (loss) income before reclassifications	(2,713)
(Gains) losses reclassified from accumulated other comprehensive income (loss) to net income	983
Other comprehensive income (loss), net of tax	(1,730)
Ending balance	416
Accumulated Unrealized Components of Defined Benefit Plans
Change in Accumulated Other Comprehensive Loss
Beginning balance	(22,476)
Other comprehensive (loss) income before reclassifications	578
(Gains) losses reclassified from accumulated other comprehensive income (loss) to net income	0
Other comprehensive income (loss), net of tax	578
Ending balance	(21,898)
Total
Change in Accumulated Other Comprehensive Loss
Beginning balance	(64,030)
Ending balance	$ (60,247)
[1]	Derived from audited financial statements

ACCUMULATED OTHER COMPREHENSI_4

ACCUMULATED OTHER COMPREHENSIVE LOSS - Components of Accumulated Other Comprehensive Loss Footnotes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 29, 2019	Dec. 23, 2018	Dec. 29, 2019	Dec. 23, 2018
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Revenue	$ 2,583,501	$ 2,522,673	$ 4,749,247	$ 4,853,364
Cost of goods sold	1,403,857	1,377,640	2,587,893	2,650,133
Selling, general, and administrative	$ 174,272	$ 169,098	331,700	$ 343,873
Accumulated Unrealized Gain or Loss on Cash flow hedges | Reclassified from accumulated other comprehensive income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Revenue			(400)
Cost of goods sold			1,600
Selling, general, and administrative			$ 700

Uncategorized Items - lrcx10q2q

Label	Element	Value
Dividends Payable	us-gaap_DividendsPayableCurrentAndNoncurrent	$ 171,196,000
Dividends Payable	us-gaap_DividendsPayableCurrentAndNoncurrent	163,510,000
Restricted Cash and Cash Equivalents	us-gaap_RestrictedCashAndCashEquivalents	255,292,000
Restricted Cash and Cash Equivalents	us-gaap_RestrictedCashAndCashEquivalents	253,907,000
Accounting Standards Update 2016-16 [Member]
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	(443,000)
Accounting Standards Update 2016-16 [Member] | Retained Earnings [Member]
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	(443,000)
Accounting Standards Update 2014-09 [Member]
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	139,355,000
Accounting Standards Update 2014-09 [Member] | Retained Earnings [Member]
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	$ 139,355,000